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Abstract 
The SCF ubiquitin ligase complex of budding yeast triggers DNA replication by 
cata lyzi ng ubiquitination of the S phase CDK inhibitor SIC I. SCF is composed of several 
evolutionarily conserved proteins, including ySKP I, CDC53 (Cullin), and the F-box protein 
CDC4. We isolated hSKP I in a two-hybrid screen with hCULI, the human homologue of 
CDC53. We showed that hCULI associates with hSKPI in vivo and directly interacts with 
hSKP I and the human F-box protein SKP2 in vitro, forming an SCF-Iike particle. Moreover, 
hCUL I comple ments the growth defect of yeast CDC53" mutants, associates with ubiquitination-
promoting activity in human cell extracts, and can assemble into functional, chimeric ubiquitin 
ligase complexes with yeast SCF compone nts. These data demonstrated that hCULI functions as 
part of an SCF ubiquitin ligase complex in human cells. However, purified human SCF 
complexes consisting of CULl , SKPI, and SKP2 are inactive in vitro, suggesting that additional 
factors are required. 
Subsequently, mammalian SCF ubiquitin ligases were shown to regulate various 
physiological processes by targeting important cellular regulators, like lKBa, ~-catenin, and p27, 
for ubiquitin-dependent proteolysis by the 26S proteasome. Little, however, is known about the 
regulation o f various SCF complexes. By using sequential immunoaffinity purification and mass 
spectrometry, we identified proteins that interact with human SCF compone nts SKP2 and CUL l 
in vivo. Among the m we identified two addi tional SCF subunits: HRTI , present in a ll SCF 
complexes, and CKS I , that binds to SKP2 and is like ly to be a subunit of SCF5K 1' 2 complexes. 
Subsequent work by others demonstrated that these proteins are essentia l fo r SCF activity. We 
a lso discovered that COP9 Signalosome (CSN), previously described in plants as a suppressor of 
photomorphogenesis, associates with CUL I and othe r SCF subuni ts in vivo. This inte raction is 
evolutionarily conserved and is a lso observed with other Cullins, suggesting that a ll C ullin based 
ubiquitin ligases are regulated by CSN. CSN regu lates Cullin Neddylation presumably through 
v 
CSNS/JAB I, a stochiometric Signalosome subunit and a putative deneddy lating e nzyme. This 
work sheds light onto an intricate connection that exists between signal transducti on pathways 
and protein degradation machinery inside the cell and sets stage for gai ning futther insights into 
regulation of protein degradation. 
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Chapter 1. Introduction 
The goal of this chapter is to provide a review of our current knowledge and 
understanding of the COP9 Signalosome and processes involved in ubiquitin-dependent 
degradation in the ce ll cycle, with emphasis on SCF ubiquitin ligase function. 
Cell Cycle Ret:ulation by Proteolysis 
In an attempt to carry on fundamental processes that keep the flame of life burning, every 
single li ving cell faces two challenges: it has to precisely duplicate its genetic information once 
and only once before each cell division and then properly segregate it to daughter ce lls. To 
accompli sh thi s, the ce ll goes though biochemically and temporarily distinct phases of the cell 
cycle. The cell replicates its DNA in S phase, then condenses its chromosomes, a ligns them on a 
microtubular spindle, and segregates them to the opposite poles in Mitosis, or M phase. The gap 
between mitosis and the onset of DNA replication is called G I phase, and the gap between S 
phase and mitosis - G2 phase. What drives cell s from o ne phase into the other and what prevents 
them from entering the next stage before completing the prior one perplexed scientific minds for 
many years. It is now clear that the general strategy employed to insure proper cell cycle 
transitions is the use of stimulating factors and inhibitory barriers that must be overco me in order 
for the transition to occur. Early cell fusion experiments led to a discovery of an M-phase 
promoting factor (MPF) capable of driving early G2 cells into mitosis. Ensuing symbios is of 
yeast genetics, frog biochemistry and mammalian tissue culture led rapidly to the current notion 
that DNA replication and mitosis are induced by the activation of S and M phase specific cyclin 
dependent protein kinases (CDKs). CDKs are activated by phosphorylation and binding to a 
variety of cyclins- key regulators of the cell cycle transitions whose abundance varies through 
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the cell cyc le. CDK inhibitors (CDKi), on the other hand, function as negati ve regulators of the 
cell cyc le by binding to Cyclin/CDK complexes and inhibiting their kinase activity. Within the 
logical framework of the cell cycle, the same molecules that are used to promote one transition 
o ften inhibit the subsequent transition. For example, in Sacharomyces cerevisiae CDK inhibitor 
SIC I promotes exit from mitosis by inactivating mitotic CLB/CDC28 kinases and acts as a 
barrier to S phase entry by inhibiting S phase CDKs. Likewise, S phase cyc lins promote 
initiation o f DNA replication but prevent the reestablishement of new competent origins thus 
preventing rereplication, while mitotic cyclins promote entry into mitosis but inhibit mitotic exit. 
Coupling of positive and negati ve regulatory signals ensures establi shment of a cell cyc le phase 
where defined sets of events occur. Once the task is accomplished, the inhibitory barriers are 
overcome to allow the transition to the next phase. 
Investigations into the nature of cyclin and CDKi periodicity led to a discovery of the 
in volvement of ubiquitin-dependent proteolysis in cell cyc le control. Ubiquitin dependent 
degradation of a subset of cell cycle regulators with dual positive/negative roles (e.g., SIC I , 
PDS I , mitotic cyc lins), whose destruction is necessary for cell cycle progression, relieves the 
negative barriers they impose on cell division, while destmction of stri ctl y positi ve cell cyc le 
regulators (e.g., G I cyclins, CDC6) is important for cellular homeostasis and resetting the balance 
of regulatory factors for the next cell cyc le. 
The G I /S transition in S. cerevisiae depends on degradation of the CLB/CDC28 inhibitor 
SIC I , which accumulates to high levels in G I , gets phosphorylated at multiple sites by 
CLN/CDC28 at the end of G I, then ubiquitinated and rapidly degraded at G I /S transition 
(Schwob et al., 1994). SIC I ubiquitination is carried out by the SCF ubiquitin ligase and CDC34 
ubiquitin conjugating enzyme (Verma et al., 1997). The same pathway is involved in the 
turnover of G I cyclins (Willems et al., 1996), which is important for the adaptation of the rate of 
ce ll division to changing environmental conditions; and CDC6, a protein essential for the 
initiation of DNA replication (Elsasser et al., 1999). In the fission yeast Schizosaccharomyces 
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pombe, degradation of the CDC6 homologue, CDC 18, may limit DNA replication to only o nce 
per ce ll cycle. Similarl y, in hig her eukaryotes, p27 CDK inhibitor accumulates at hig h leve ls in 
quiescent ce ll s and is rapidly degraded though an SCF pathway when cells are stimulated by 
growth factors (Carrano et al. , 1999; Pagano et a l. , 1995). Human G I cyclins, E and D I , were 
a lso shown to be substrates o f the SCF pathway (Singer et al., 1999; Yu et al. , 1998). 
Mitotic events are regulated by a diffe rent ubiqu itin-dependent pathway, involving 
A PC/Cyclosome. Si ster chromatid separation at the onset of anaphase is triggered by degradation 
of an anaphase inhibitor PDS I (Cohen-Fix et al. , 1996), and ex it from mitosis requires 
degradatio n of mitotic cyclins (Hershko, 1999). Inacti vation of any one of at least ten APC 
subunits prevents cyclin destruction and sister chromatid separation (Irniger et a l. , 1995). 
Budding yeast ASE I , a prote in locali zed in the midzone o f the mitotic spindle and required for 
spindle e longation, is also an APC substrate (Juang et al. , 1997). 
The Ubiquitin System 
Ubiquitin is one of the most conserved eukaryotic prote ins. It is a small 76-amino acid 
prote in involved in a variety of cellular fun ctions, including regulation of intracellular prote in 
degradation, antigen processing, cell cycle progression, receptor endocytosis, and s igna l 
transduction. Ubiquitin (Ub) is conjugated to other prote ins inside the cell through a well-defin ed 
enzymatic pathway (Hershko and Ciechanover, 1998). It begins with an ATP-dependent 
activation of a Db-activating enzyme, E I , which acti vates Ub through adenylation and 
subsequently forms a high-ene rgy E 1-Ub thio l ester. In yeast, UBA I is essential for viability and 
encodes a I 14 kDa activating enzyme required for ubiquitin conjugation (McGrath et a l., 199 1 ). 
Next, ubiquitin is transferred to a ubiqui tin-conjugating enzyme, E2, which also forms a thio l 
ester bond with Ub. Mo re than 30 E2 enzymes have currently been identified . Finall y, Ub is 
transferred to a target prote in through an isopeptide linkage between the conserved C-te rminal 
G ly res idue o f Ub and £-amino group of the Lys res idue of the target prote in. Sequential 
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conjugation of the internal Lys residue of Ub to a C-terminal Gly residue of a new Ub molecule 
results in a formation of polyubiquitin chains which target proteins for degradation by the 26S 
proteasome (Pickart and Rose, 1985). The proteasome is a large, 26S, multicatalytic protease that 
degrades polyubiquitinated proteins to small peptides (Voges et al. , 1999). It is composed of two 
subcomplexes, a core catalytic 20S particle and a regulatory 19S pa1ticle. The 20S complex is 
barrel-shaped and consists of four stacked rings, two identical outer a rings and two identical 
inner~ rings. The a and ~rings are composed each of seven distinct subunits, giving the 
complex the general structure of a1 •7~ 1 •7~ 1 •7a 1 •7 • The catalytic sites are localized in some of the~ 
subunits. Each extremity of the 20S complex is capped by a 19S particle. The yeast 19S 
complex has been further resolved into two sub-complexes, the ' base', which consists of six 
ATPases of the AAA family and three add itional proteins, and an 8-subunit ' lid' that is 
homologous to COP9 Signalosome (see below). 
In many cases, the transfer of Ub from an E2 to a target protein requires the involvement 
of a ubiquitin-ligase, E3, that is discussed in detail in the next section. 
SCF and Other Ubiguitin Ligases 
E3 ubiquitin ligases cooperate with E2 ubiquitin conjugating enzymes to assemble 
polyubiquitin chains on substrate proteins. Generally, ubiquitin ligases, whether si ng le proteins 
or multi-protein complexes, contain protein-protein interaction domains that provide substrate-
binding activities, and catalytic domains that promote ubiquitin transfer from an E2 enzyme to a 
substrate molecule. Based on sequence homology and catalytic principles involved, all know 
ubiquitin ligases can be divided into two major c lasses: HECT domain and RING finger based 
ubiquitin ligases. 
HECT domain proteins provide a simple and general model for an E3 function. They are 
found broadly in eukaryotes and are defined by a 350 amino acid C-tennina l HECT homology 
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domain (Homologous to .E6-AP G-I erminus), orig inally identified in E6-AP (Sche ffn er et a l. , 
1993). E6-AP is the cellular ubiquitin ligase recruited by the human papi lla ma virus E6 
o ncoprote in to induce degradatio n o f the p53 tumor suppressor. A conserved Cys residue within 
the cata lyti c HECT domain of E6-AP forms a thiol ester with ubiquitin mo lecu le which is then 
transferred to p53 (Scheffner et al., 1995). Multiple HECT domain prote ins have been identified , 
inc luding N EDD4 in humans; RSPS, UFD4, and TOM I in S. cerevisiae; and Pub I in S. pombe. 
In a ll o f them, it appears that the large N-te rmina l domains confe r the ability to bind substrates 
and the C-termina l HECT do mains serve to directl y transfe r ubiquitin to the substrates through a 
E l-E2-E3 ubiquitin thio l ester cascade. 
The identification of RING finger domains in SCF complexes and othe r non-HECT 
domain ubiquitin ligases suggested that these domains a re functiona lly sig nificant in 
ubiquitination. RINGs are zinc-binding domains with a defined octet of Cys and His residues in a 
consensus sequence CX2CX(9-39)CX( I-3)HX(2-3)C/HX2CX(4-48)CX2C (Jackson et al. , 2000; 
Saurin et al. , 1996). RING fingers are subcategori zed into RING-H2 (found in HRTI , HRT2, and 
A PC I I ) and RING-HC (found in severa l othe r li gases) depending on whether a Cys or His 
occupies the fifth coordination site, respecti vely. Stuctures of RING finger prote ins show two 
interleaved zinc binding sites, in contrast to the tande m arrangements o f z inc binding sites o f z inc 
fingers. In contrast to HECT domain ubiquitin ligases that form thio l esters with ubiquitin , the re 
is no evidence for such intermediates invo lving RING finger E3s (Seal et a l. , 1999). Since RING 
finger proteins can directly bind to E2 e nzymes (Zheng et al. , 2000), it is like ly that RING fingers 
mediate ubiquitination by recruiting E2 enzymes to the vic inity o f prote ins to be ubiquitinated, 
thus facilitating the direct transfe r of Ub from E2s to target prote ins. However, there is evide nce 
that the ro le o f the RING finger is more complex. For example, UBR I binds its cognate E2, 
RAD6, predo minantly through regions outside the RING, yet mutations in this region only 
weakly reduce E3 acti vity, while a mutation in the RING did not affect binding to E2 or substrate, 
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but abolished ubiquitination (Xie and Yarshavsky, 1999). One possibily is that the RING may 
function as an a llosteric activator of an E2. 
RING finger E3s play promine nt ro les in di verse cellular processes, inc luding cell cycle, 
sig na ling, transcription , apoptosis, pro liferation, and DNA repa ir. In one of the well unde rstood 
examples, CBL, a n adapte r prote in containing both SH2 and RING-HC fin ger do mains, functions 
as a ub iquitin ligase that recognizes phospho rylated tyros ine on receptor prote in-tyrosine kinases 
(RPTKs) through its SH2 domain and terminates signaling by mediating acti ve receptor 
ubiquitination and degradation (Joazeiro et a l., 1999). Oncogenic versions of CBL contain 
de letio ns or point mutations in the RING do main, suggesting that C BL becomes transforming by 
los ing the activity of the RING finger and presumably ubiquitin- ligase acti vity. 
T he SCF subfa mily o f RING finger E3s was o rig ina lly discovered a nd ex tensively 
studied in budding yeast S. cerevisiae. SCF complexes consist o f at least four subunits: 
C DC53/CULI , HRTI /RBX 1/ROC I, S KPI and one of the F-box family of proteins (Fe ldman et 
al. , 1997). All known SCF subunits are highly conserved throughout eukaryotes. Cullin and the 
RING finger protein HRTI form a cata lyti c core of E3 that binds to and acti vates E2 CDC34 or 
UBCH5 (Seol et al. , 1999). Cullin/CDC53 has three functional do mains: an N-terminal domain 
that binds SKP I (Michel and Xiong, 1998; Patton et a l. , 1998), an interna l Cullin homo logy (CH) 
domain that recruits CDC34 and HRT I (Ohta et a l. , 1999), and a short C-termina l domain which 
is the most conserved part of the protein that contains neddylation dete rminants (Lam mer et al. , 
1998) and is probably in vo lved in the regulation of SCF activity, as discussed in the next section. 
HRT I is a sma ll 12 1 amino acid RING finger protein that binds directl y to Cullins and CDC34, 
like ly tethering E2 to the CH domai n. SKPI binds to the CDC53/HRTI core and mediates 
recruitme nt o f various F-box adapte r proteins, which contain a -45 a mino acid moti f called an F-
box and bind to substrates thro ug h prote in-protein interaction do mains, thus conferring substrate 
specific ity to this family of E3s. Multi ple F-box prote ins have been shown to bind SKPI . Th is 
interactio n requires an intact F-box a nd some outside seque nces (Ba i et a l. , 1996), and is direct 
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(Lyapina et al. , 1998; Schulman et a l., 2000). The N-tenninal - I 00 amino ac id domain o f SKP I 
contains both a Cullin-binding site and an F-box binding dete rminant, a lthough downstream 
sequences might stabilize associatio n of SKPI with diffe rent F-box prote ins (Miche l and Xiong, 
1998; Ng et a l. , 1998). There are over 400 F-box prote ins currently in the database, with 20 F-
box proteins in S. cerevisiae, over I 00 in C elegans, and -50 described so far in vertebrates 
(Skowyra et a l. , 1997). All F-box proteins can be di vided into three c lasses, based on the 
assoc iated protein-prote in inte raction domains: Fbw, containing WD40 repeats, e.g., CDC4 and 
~TrCP; Fbi, containing leuc ine-rich repeats (LRR), e.g., GRR I and SKP2; and Fbx, containing 
other repeats or unique sequences (Cenc iarelli et a l. , 1999; Regan-Rei mann et a l. , 1999; Winston 
et a l. , 1999). 
SCF acti vity might be d irectly involved in regulating the abundance and repe rto ire of 
various SCF complexes. The F-box prote ins CDC4, G RR I, and MET 30, are unstable and are 
degraded in a proteasome- and SCF-dependent manner (Galan and Pete r, 1999; Mathias et a l. , 
1999; Z hou and Howley, 1998). It has been proposed that substrate binding to an F-box prote in 
protects it from auto-ubiquitination, thus insuring that there is a direct corre lation between the 
concentration of an F-box protein and the concentration of its targets, and that the core ubiquitin 
ligase is being effecti vely recycled between various SCF complexes (Deshaies, 1999). 
Many proteins have been implicated as substrates of the SCF pathway. These proteins 
partic ipate in a variety of cellular functions, inc luding regulation of CDK acti vity, activation of 
transc ri ption, signa l transduction, and DNA replication (Deshaies, 1999). In a ll studied cases, 
phosphory lation of the substrates is required for recognition by the F-box proteins. In the 
SCFmc4 complex, each of the known substrates, SIC I (Feldman et al. , 1997), CDC6 (Elsasser et 
a l. , 1999), and GCN4 (Kornitzer et al. , 1994 ), must be phosphorylated before they can be 
recognized by the WD40 repeat ~-propeller domain of CDC4 and ubiquitinated. Another WD40-
repeat prote in conta ining SCF complex, scpPTrCP' recognizes a specific phosphoserine moti f 
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(DSG_XS) found in its substrates IkBa and ~-catenin (Fuchs et a l. , 1999; Winston et al., 1999; 
Yaron et al., 1998). G I cyclins (Deshaies et al. , 1995) and p27 (Pagano et al. , 1995), the known 
substrates of the LRR-containing F-box prote ins GRR I and SKP2, respective ly, also follow the 
same rule. This mechanism a llows for diffe rential temporal regulation of SCF substrate stability 
in the presence of fully active SCF complexes. 
SCF might serve as a prototype for other modular Cull in-based ubiquitin ligases. The re 
are at least five other human Cullins, which, in contrast to CULl, do not bind SKPI. Human 
CUL2 binds to the von Hippe l-Lindau gene product (VHL) through e lo ng in B and e long in C 
(which shares homology with theN-terminal region of SKP I) to form a complex (CUL2-VBC) 
which appears to have ubiquitin ligase activity (lwai et al. , 1999; Kamura et a l. , 1999; Lisztwan et 
al., 1999). YHL down-regulates hypoxia-inducible mRNAs, presumably by controlling 
proteolysis of hypoxia regulated transcription factors HIF I a and HIF2 a (IIiopoulos et al., 1996; 
Krek, 2000; Stebbins et a l. , 1999). YHL can be replaced in this complex by SOCS box-
containing proteins, which, analogous to F-box proteins, might confer substrate speci fic ity 
(Desha ies, 1999). Human CUL3 was recently shown to be involved in the ubiquitination of 
Cyclin E and control of S phase in mammalian cells (S inger et a l. , 1999). Human CUL4 
associates with UY-damaged DNA binding protein and may play a role in DNA repair (Shiyanov 
et al. , 1999). The RING finger protein HRTIIRBX I !ROC I, a core component of SCF ubiquitin 
li gases, has been shown to interact with all Cullins (Kamura et al. , 1999; Ohta et a l. , 1999; Seol et 
al. , 1999). Thus, Cullins may define a family of E3 ubiquitin ligases that have diverse biological 
functions. 
Another prominent RING finger-containing E3 is the Anaphase Promoting Complex 
(APC/Cyclosome) which is required for the methaphase to anaphase transition and exit from 
mitosis (Cohen-Fix et a l. , 1996; King et a l., 1995; Yeong et al. , 2000) APC is a multicomponent 
ubiquitin ligase that consists of at least 12 essential subunits, including Cullin family member 
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APC2 and a RING-H2 protein APC II (Gmachl et a l., 2000; Leverson et al. , 2000; Yu et al. , 
I 998). Also, like SCF, APC associates with WO repeat-containing adapter prote ins 
COC20/Fizzy, COH I /HCT I / Fizzy-re lated, and AMA I, that acti vate APC toward speci fi e 
substrates (Cooper et al. , 2000; Yisintin et al. , 1997). Whereas APCCDC20 is active at the 
beginning o f anaphase, when it targets the anaphase entry inhibitor POS I for degradation, 
APCcm11 is required for the degradation o f Cyclin B at the end o f mitosis. Both C OC20 and 
HCTI are regulated: COC20 - by binding to an inhibitory MA02 checkpo int prote in (Fang et a l. , 
I 998) and degradation though APCco11 1, and COH I - by inhibitory phosphorylation by Cyclin 
B/COK (Kramer et al. , 2000; Zachariae et al. , 1998). COC20 binding to APC also requires 
phosphorylation o f APC by a mitotic kinase (Kramer et al. , 2000). APC substrates a re ta rgeted 
fo r ubiquitination and degradation through two destruction signa ls: the 0 (destruction) box and 
the KEN box (Pfleger and Kirschner, 2000). The 9 amino acid 0 box is found in a ll known 
APCCDC2o substrates, but also in some APCm111 substrates. The KEN box is a 7 amino ac id motif 
that appears to target substrates to APCm111 • 
Ubiguitin-like Proteins 
The complexity of the ubiquitin pathway is further compounded by the ex istence of 
severa l ubiquitin-like proteins, name ly, UCRP (!!.biquitin hross-reacti ve p.rote in), sentrins, 
APG 12, URM I, and NE008 (see Table I). UCRP is a type I interferon-inducible prote in that 
conta ins two ubiquitin do mains (Narasimhan et a l. , 1996). UCRP has been shown to conjugate to 
a large number of intrace llular prote ins, the identities o f which have not been determined. Recent 
stud ies suggest that UCRP conjugation proceeds though an enzymatic pathway that is distinct 
from that o f ubiquitin , at least with respect to the activation step. However, the identity of the 
UCRP acti vating enzyme remains unknown. 
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The sentrin family of ubiquitin-like proteins consists of three family members that have 
s imilar substrate specificity: sentrin I, sentrin 2, and sentrin 3. These proteins are able to 
conjugate to Ran GAP I, Ran BP2, PML, p53, IKBa, and yeast septins among others (Yeh et al., 
2000). Sentrins and SMT3 (their yeast homologue) are 95-103 amino acid long proteins with 
almost 20% identity and 50% homology to ubiquitin. They are activated by an E 1-like protein, 
UBA2, which encodes a 71 kDa protein that is s imilar to the C-terminus of E I and bears a Cys 
residue at a position similar to the active-site Cys of UBA I (Dohmen et al., 1995). UBA2 
cooperates with another 40 kDa protein, termed AOS I , to conjugate sentrin (SMT3 in yeast) to 
target proteins (Johnson et al., 1997). Both human and yeast AOS I and UBA2 share extensive 
homology with theN- and C-terminal ha lves of yeast UBA I. Both sentrins and SMT3 utilize 
UBC9 as the conjugating e nzyme (Johnson et al., 1997), which forms thiol esters with all sentrin 
proteins, but not ubiquitin or NEDD8 (Gong et al., 1997). All components of the SMT3 
conjugation pathway are essential in yeast. 
Table 1. Ubiquitin-like proteins 
MODIFIER ACTIVATING CONJUGATING LIGASE SUBSTRATE FUNCTION 
ENZYME ENZYME E3 
El E2 
Ublquitin UBAI UBCI- SCF, APC, p27, IKBa, Proteasome-
8,10,11, 13 etc. Cyclins, etc. dependent 
degradation 
Endocytosis 
UCRP ? ? ? ? ? 
Sentdn/SMT3/ AOSI/UBA2 UBC9 ? PML, lKBa, Targetting? 
SUMO! RanGAP I, etc. 
NEDD8/RUB1 ULAI/UBA3 UBCI2 SCF, VBC, Cullins Regulation? 
etc. 
APG12 APG7 APG IO None APGS Autophagy 
APGS APG7 ? Phosphatidyl- Lipidation 
ethanolamine 
URMl UBA4 ? ? ? ? 
I 1 
NEDD8 is a sma ll prote in o f 8 1 amino acids, which is 60% identical and 80% 
homologous to ubiquitin . The yeast and plant homologues of NEDD8 are called RUB I (re lated 
to ubiquitin I ) (de l Pozo and Estelle, 1999; Lam mer et a t. , 1998; Liakopoulos et at., 1998). 
Unlike ubiquitin , which is detectable equally in the nuc leus and cytosol, N EDD8 is highly 
enriched in the nuc leus (Kamitani et at. , 1997). In contrast to sentrins, the overall structures of 
NEDD8 and RUB I are more c losely related to ubiquitin (Rao-Naik et a t. , 1998; Whitby et a t. , 
1998). The activating enzyme complex fo r human NEDD8 is composed of two subunits: APP-
BP I (also known as AXR I in plants and Uta I /Enr2 in yeast) and UBA3 (Ecr I in plants), which 
are homologous to the N- and C-terminal halves of ubiquitin E I , respecti vely. UBA3 conta ins 
the acti ve site Cys residue required for the formation o f a thio l este r linkage with N EDD8 and 
b inds pre fe rentia lly to NEDD8, but not ubiquitin or sentrin (Gong and Yeh, 1999). UBC 12 
functions as an E2 for NEDD8 and RUB I (Liakopoulos et a t. , 1998) and a dominant-negati ve 
fo rm of UBC 12 can abolish NEDD8 conjugation in vivo (Wada et at. , 2000). 
T he RUB I conjugation system in plants is involved in the normal developmental 
respo nse to the hormone auxin (Pozo et at. , 1998). Cullins are the major and only known targets 
o f N EDD8 modification in yeast, plants , and mammals. Budding yeast C DC53/Cullin is required 
fo r G I IS progression and is a subunit of an SCF ubiquitin ligase that targets CDC28 inhibitor 
S ic I for degradation, a llowing cells to initiate DNA replication (Feldman et at. , 1997; Verma et 
a t. , 1997). RUB I is non-essential in budding yeast S. cerevisiae, but genetic evidence suggests 
that the inability to modi fy CDC53 by RUB I renders cells sensitive to a lte rations in the levels of 
the SCF components CDC4, C DC34, and CDC53, suggesting that RUB I conjugation to CDC53 
is required for o ptimal fun ction o f SCF complexes. In fi ssion yeast, however, the Nedd8 
modificatio n pathway plays an essentia l ro le in SC F function (Osaka et at. , 2000). Di sruption o f 
the genes encoding Nedd8, UBA3, or Ubc 12 is letha l. The Cullin I ortho log in S. pombe. Pcu I , 
is complete ly modified by Nedd8 when assembled in SCF complexes. A Pcu I Km R mutant that is 
defecti ve for Nedd8 conjugation does not complement the lethality of pcu I de letion. Forced 
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expression of Pcu I K?IJR or depletion of Nedd8 results in impaired cell proliferation and 
stabilization of the CDK inhibitor Rum I, which is functionally homologous to budding yeast 
Sic I , and is a substrate of the SCF complex. Human Cu llins, CUL I -5, are a lso modified by 
NEDD8 (Hori eta!., 1999), and NEDD8 modification of the Cullins may play a crucial role in 
establishing their ligase activity. NEDD8 modified CUL I and other SCF components are 
enriched in the centrosome, suggesting that NEDD8 modified SCF is involved in centrosome 
duplication (Freed et al., 1999). Accumulated evidence suggests that conjugation of NEDD8 to 
CUL I greatly enhances SCF activity. Covalent linkage of NEDD8 to bacterially expressed 
CUL I is both necessary and sufficient to enhance the ability of the SCF core ubiquitin ligase to 
promote polyubiquitin chain formation (Wu et al., 2000). Moreover, a K720R mutation in CUL I , 
which e liminates NEDD8 modification significantly reduces the abi lity of SCFPT•o> to support 
ubiquitination of phosphorylated lKBa, and ~-catenin (Read et al., 2000). Similarly, p27 
ubiquitination activity in cell extracts depends on the presence of the ubiquitin-like protein 
NEDD8 and enzymes that catalyze NEDD8 conjugation to proteins. Moreover, reconstitution of 
the p27 ubiquitination activity with recombinant SCFsKrz also requires NEDD8 conjugation 
pathway components. Inactivation of the NEDD8 conjugation pathway by a dominant negative 
mutant of the NEDD8-conjugating enzyme UBC 12 blocks the ubiquitination and degradation of 
p27 in cel l extracts (Podust et al., 2000). 
Unlike sentrins and NEDD8, three other recently discovered modifiers, APG I 2, APG8, 
and URM I , do not show apparent overal l homology to ubiquitin and other related proteins, but 
nevertheless are components of protein conjugation pathways with striking resemblance to that of 
ubiquitin. URM I is a 99 amino acid protein that possesses the C-terminal Gly-Giy motif, which 
is a common feature of ubiquitin and ubiquitin-re lated modifiers (Furukawa eta!., 2000). A 
portion of UBA4 protein, which serves as an activating enzyme for URM I , has high similarity to 
regions in other E !-like enzymes, including an ATP-binding motif and a conserved Cys residue. 
13 
URM I is covalently attached to at least one protein inside the cell , presumably through an 
isopeptide bond. The exact function of the Unn I system and its other components are still to be 
determined. 
A lot more is known about the APG 12 and APG8 conjugation pathway that is conserved 
from yeast to humans and is required for autophagy, a process responsible for non-selective 
degradation of cytoplasmic components in the lysosome (Mizushima et al., 1998). APG7 shows 
significant homology with theE I Ub-activating enzyme UBA I and forms a thiolester bond 
between its active-site Cys residue and a carboxy-terminal Gly residue of a 186 amino acid 
protein APG 12 (Tan ida et al., 1999). The activated APG 12 is transferred to APG5 through 
formation of an isopeptide bond between Lys residue of APG5 and the C-tenninal Gly residue of 
APG 12. Un like the Ub-mediated conjugation system, APG5 appears to be the on ly target for 
activated APGI2. APGI2-APG5 conjugation depends on APG IO and, although it shows no 
homology to E2 Ub carrier enzymes, APG I 0 acts as a protein-conjugating enzyme (E2) for the 
APG 12 modifier. Apg8 is also activated by an E I protein, Apg7, and is transferred subsequently 
to the E2 enzyme Apg3 (Ichimura et al., 2000). Apg8 is then covalently conjugated to 
phosphatidylethanolamine through an amide bond between the C- terminal g lycine and the amino 
group of phosphatidylethanolamine (lchimura et al. , 2000). This lipidation has an essentia l role 
in membrane dynamics during autophagy. 
Deubiquitinating and Deneddylating Enzymes 
Because of its irreversibility, protein degradation requires precise timing and specific 
recognition of different substrates at appropriate cellular milieu. This is thought to be mediated 
by a combinatorial usage of different E2 and E3 enzymes and by a large family of 
deubiquitinating enzymes (Wilkinson and Hochstrasser, 1998). Deubiquitinating enzymes are 
ubiquitin-specific thiol proteases that cleave either linear ubiquitin precursor proteins or ubiquitin 
conjugates. Some deubiquitinating enzymes appear to perform an editing function, which 
controls the fidelity of the conjugation process, thus preventing inappropriate degradation of 
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cel lular proteins (Kam et al., 1997). Two families of deubiquitinating enzymes have been 
identified on the basis of in vitro activities and/or sequence identity. The ubiquitin C-terminal 
hydrolases (UCHs) are small (approximately 25 kDa) thiol proteases that share amino acid 
sequence identity and cleave esters and am ides from the C terminus of ubiquitin. Unrelated in 
sequence to the UCHs are the ubiquitin-specific proteases (UBPs), a large fami ly of proteins 
differing great ly in length but characterized by sequence similarity in several regions: the Cys 
box, the His box, and six other blocks of amino ac id sequence identity. The proteases specific for 
other ubiquitin-like proteins, Sentrin I and SMT3, are structura lly different from the ubiquitin-
specific UBPs and the UCHs. However, some of the UCHs and UBPs may have dual specificity 
for both ubiquitin and NEDD8. For example, UCH-L3, which was originally identified as a 
ubiquitin-specific hydrolase, was found to possess NEDD8 C-terminal hydrolase activity (Wada 
et al. , 1998). Recently, a novel UBP, USP21, capable of deconjugating ubiquitin from 
ubiquitinated proteins, was shown to be capable of removing NEDD8 from NEDD8 conjugates, 
but not Sentrin I from Sentrin I conjugates (Gong et al. , 2000). It is not known whether this 
overlap is limited to certain UBPs and UCHs, or is a genera li zed property of these enzymes. It is 
also possible that there is a family of NEDD8-specific proteases yet to be discovered that are 
structurally different from UBPs and UCHs. 
Cop9 Signalosome 
To grow and develop normally , a ll organisms need to perceive and process information 
from both their biotic and abiotic surroundings. Animal cells are influenced by the availability of 
nutrients and growth factors. In plants, a particularly important environmenta l cue is light, to 
which organisms respond in many different ways. Plants have developed highly sophisticated 
photosensory and transductory mechanisms to allow the modulation of development in response 
to light intensity, wavelength, duration, and direction. After germination, the young plant 
seedling must choose between two developmental programs, depending on the available light. In 
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the absence of lig ht, seedlings undergo skoto morphogenesis, characte ri zed by a long hypocotyl 
(primary stem), an apical hook, and unopened cotyledons (embryonic leaves)- features that 
a llow the seedling to grow through a layer of soil and emerge in the light. Light induces the 
photo morphogenic program, a develo pmenta l process that optimizes the body plan of the seedling 
for effi cient photosynthetic growth. During photomorphogenesis, a new gene express ion 
program is induced, the rate of hypocotyl g rowth decreases, the apical hook opens, coty ledons 
expand, and chlo roplasts develop. 
COP9 Signa losome (CSN) was orig ina lly discovered in Arabidopsis thaLiana as a 
suppressor o f the photomorphogenic program. T here are two types of photomorphogenic mutants 
in A. thaLiana. The first group of mutants displays the dark grown characteri sti cs when grown in 
specific light conditions and probably represent mutations in genes encoding downstream 
components of the light s igna ling cascade. The mutants in the second group, which inc lude 
mutations in CSN subunits, exhibit light-grown seedling characte ri stics when grown in darkness 
(W ei et a l. , 1994). 
Sig nalosome consists of eight subunits (CSN 1-8) (Wei and Deng, 1998). Interesting ly, 
subunits o f the COP9 S ignalosome posses significant sequence homologies with the lid subunits 
of the 19S regulator of the 26S proteasome (see Table 2) (Seeger et a l. , 1998; Wei et al. , 1998) 
and with the translationa l initiation complex ei F3 (Glickman et a l. , 1998). The 19S regulator 
consists of two subcomplexes: the base and the lid (see above). Six subunits of the CSN, 19S lid, 
and severa l subunits of ei F3 contain PCI domains (for Eroteasome, ~OP9 , Initiation Facto r 3) 
(Table 2). The PCI domain is a purely a-he lical domain of -200 amino acid residues, which is 
gene rally loca li zed at the ex treme C-terminus of the prote in (Hofmann and Bucher, 1998). The 
PCI domain does not conta in any invariant residues or any conserved patte rn of cha rged residues 
that would suggest cata lyti c acti vity. 
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Table 2. COP9 Signalosome subunits 
SUBUNIT OTHER MW (KDA) l9S LID % DOMAIN 
NAMES COUNTERPART IDENTITY 
CSNl GPSI 57 Rpn7 22 
CSN2 Tripl5 5 1 Rpn2 2 1 
CSN3 SGN3 46 Rpn3 20 
CSN4 45 Rpn5 19 
CSN5 JAB I 38 Rpnll 28 
CSN6 hVTP 36 Rpn8 22 
CSN7a,b 30 Rpn9 15 
CSNS hCOP9 23 Rpnl2 18 
A second domain (MPN) is observed in two subunits of the CSN, 19S lid , and eiF3 
complexes. The MPN domain is distinct from the PCI domain. It spans - 140 amino acid 
residues, typically is present at the N-tenninus of proteins, and is predicted to have an 
a/~ structure. All proteins containing PCI and MPN domains appear to be part of large 
multiprotein compexes. 









evolved from a common ancestor and still exhibit similarities in structure and function. E lectron 
microscopy studies suggest that while a common architectura l plan for the two complexes could 
not be deduced, both COP9 Signa losome and 19S proteasome lid lack any symmetry in subunit 
arrangement and exhibit a central groove, possibly qualified for scaffolding functio ns (Kape lari et 
a l. , 2000). Cellular localization of CSN complex is similar to that of the 26S proteasome and is 
mostly nuc lear and perinuclear (Chamovitz et al., 1996; Wei and Deng, 1998). The exact 
function of the CSN is likely to be different from the 19S lid complex and remains largely 
e lusive. COP9 Signalosome is essential for development of Drosophila melanogaster (Freilich et 
a l. , 1999) and haplo insufficiency of CSN subunit 3 might be responsible for developmental 
disorders in the Smith-Mergen is syndrome (Elsea et a l., 1999). Several lines of evidence suggest 
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that CSN has a role in signal tranduction processes. CSN I was previously identified as GPS I, 
which was isolated as a suppressor of the lethality of an S. cerevisiae mutant lacking a subunit of 
a tri meric G protein (Spain et a l., 1996). Overexpression of CSN I in mammalian ce lls inhibits 
JNK and represses JUN-dependent promoter activity. CSN I a lso contains canonical MAP 
kinase kinase (MAPKK) activation loop motifs (Seeger et al., 1998). The purified complex is 
associated with a kinase that phosphorylates transcriptiona l regulators such as c-Jun, IKBa, and 
pI 05 (Seeger et al. , 1998). CSN subunits 2 and 7 are also phosphorylated by the associated 
kinase activity (Kape lari et al. , 2000). CSN2 is also known as Trip 15, which was identified in a 
two-hybrid screen as a protein that interacts with the thyroid hormone receptor and the retinoic 
acid receptor (Lee et a l. , 1995). CSN5 was described previously as JAB I (JUN activation 
domain binding prote in I) and was shown to inte ract with JUN and coactivate JUN mediated 
gene expression (Claret et a l. , 1996). JAB I inte racts with p27 CDK inhibitor, causes its expo rt 
into the cytosol, and promotes its degradation th rough an unknown mechani sm (Tomoda et al., 
1999). Interestingly, CSN5 is the only Signalosome subunit that is found in both complexed and 
mo nomeric form in vivo (Kwok et a l. , 1998). Monomeric CSN5 seems to be cytoplasmic, while 
CSN5 complexed with Signalosome is nuclear. Notably, CSN5 has the highest homology (28% 
identity) to its 19S lid counterpart than any other CSN subunit. It a lso contains a conserved Cys 
which is flanked by a highly conserved sequence with similariti es to the active site "Cys box" 
seen in many deubiquitinating enzymes. CSN6 interacts with HIV -I Ypr prote in and is a 
potential host cell target responsible for the viral Ypr-induced cellular differentiation and growth 
arrest (Maha lingam et al., 1998). Inte restingly, cells express ing antisense CSN6 were blocked at 
G2/M phase, suggesting that CSN might have a role in cell cycle progression. Similar to CSN I, 
CSN6 polypeptide has MAPKK activation loop motifs . While there does not seem to be a 
complete CSN complex in S. cerevisiae, CSN was described in S. pombe (Mundt et al., 1999), 
which indicates that fission yeast is evolutionarily much c loser to metazoans than budding yeast. 
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Fission yeast ce lls that lack CSN I (!J.caal cells) experience significant problems in passing 
through S phase and are synthetica lly lethal with S/M checkpoint mutants, suggesting that !J.caal 
cells require checkpoint function for viabi lity. 
More is known about CSN function in plant photomorphogenesis. A number of genes 
that regulate photomorphogenesis but are not part of COP9 Signalosome have been identified in 
A. thaliana. Two important components of this photomorphogenic pathway are Hy5 and COP I, 
which act antagon istically in regulation of photomorphogenic development (Ang et a l. , 1998). 
Hy5 is a bZIP transcription factor that binds directly to the light response e lements in the 
promoters of the light-inducible genes and activates their transcription (Chattopadhyay et al., 
1998; Oyama et al., 1997). Hy5 abundance inversely correlates with light intensity: Hy5 protein 
levels are highest in light-grown seedlings and rapidly decline in the dark due to 26S proteasome 
dependent degradation (Osterlund et al., 2000). Hy5 degradation in the darkness requires CSN 
and the product of COP I gene. COP I is a repressor of photomorphogenesis and is not a 
component of the CSN complex. In the dark, COP I protein locali zes to the nucleus and represses 
Hy5 activity (Osterlund et al., 1999). Light stimulus leads to COP I relocalization into the 
cytoplasm. COP9 Signalosome positively regulates COP I function and cellular loca li zation by 
either promoting nuclear accumulation of COP I or perhaps inhibiting its export from the nucleus 
(Chamovitz et al., 1996) (Fig. I). 
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Figure 1. The model of plant photomorphogenesis 
COP I contains anN-terminal RING-HC finger domain, which interacts with a RING-H2 
protein CIP8 (Torii et al., 1999), a coiled-coil motif, and a C-terminal WD40 repeat domain that 
directly binds to HyS protein (Torii et al., 1998). Given the striking parallels between COP! 
domain structure and SCF ubiquitin ligases it is likely that COP I is part of a yet to be described 
multi-domain ubiquitin ligase that regulates photomorphogenesis by targeting the critical 
transcription factors for degradation in the dark (Osterlund et al., 2000). 
Future Directions 
Recent discovery of Cullins and SCF ubiquitin ligases and some of their targets rekindled 
the interest in ubiquitin-mediated protein degradation within the scientific community. Although 
we now understand the general architecture of CUL I and CUL2-based ubiquitin ligases, many 
more questions are brought to life with each new advance in the field. First, the components of 
other Cull in-based ubiquitin ligases remain a mystery. Recent recruitment of mass spectrometry 
to the arsenal of research tools avai lable to molecular biologists and biochemists (Seol et al., 
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1999) should aid considerably in the e luc idation o f other ubiquitin ligase components. Second, 
a lthough a number of substrates of Cull in-based ubiquitin ligases have been discovered , this 
discovery was large ly dri ven by educated guessing. Once this resource is exhausted , c lever 
genetic, bioche mical, or pharmacological screens would have to be devised to continue with the 
progress. Third, as the network of Cullin based ubiquitin ligases and the ir substrates emerges, 
unde rstanding the regulatio n of this network and its connectio ns to the signa l transduction 
network will become an interesting intellectual challenge. The discovery of SCF regulation by 
COP9 S igna losome, described here, sets the stage for furthe r research on the regulation of 
intrace llular prote in degradation. Major questions, e merg ing from this study, are : 
• does CSN have othe r activities besides promoting deneddylation? 
• is CSN acti vity regulated? If so, how? 
• how does CSN influence Cullin ubiquitin ligase acti vity, apart fro m regulation of Cullin 
neddylation? 
• are all neddylated prote ins regulated by CSN deneddylating acti vity? 
• what are other neddylated prote in a ffected by CSN? 
• are other ubiquitin ligases a lso regulated by CSN? 
• how does CSN integrate various sig na l transduction pathways and re lay them onto its 
substrates? 
• does CSN associate with an ATPase, analogous to the 19S base pa rtic le? 
As a rule, bas ic structural components of many biological pathways tend to be 
evolutionaril y conserved, unlike the regulatory networks they o rgani ze into. Thus, although 
building materi a ls of Cullin based ubiquitin ligases would likely be very s imilar across species, 
the regulation o f their acti vity might differ s ignificantly between species. The g limpses of these 
d ifferences can be seen a lready. Whereas SCF components are evolutionarily conserved in 
budding yeast, fiss ion yeast, plants, d rosophila, and animal cells, COP9 Signalosome is not. CSN 
is absent in S. cerevisiae, except for JAB I homologue, is present but not essentia l in S. pombe 
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(Mundt et al., 1999), A. thaliana (Wei and Deng, 1992), is essential in D. melanogaster (Freilich 
et al., 1999), and more than likely, animal cel ls. Thus, it seems that CSN function gained 
importance in parallel with evolving complexity of signal transduction pathways, and therefore 
became essentia l in multicellular organisms with intricate communication between cells within an 
organism. As reported here, CSN harbors a deconjugating activity towards RUB I/NEDD8. 
Interesting ly, the RUB I/NEDD8 modification pathway is dispensable inS. cerevisiae (Lammer et 
al., 1998; Liakopoulos et al., 1998) and A. thaliana (Pozo et al., 1998), but is absolutely essential 
inS. pombe (Mundt et al., 1999), and, possibly, animal ce lls. Additiona lly, CSN seems to 
positively regulate COP I putative ubiquitin ligase activity in plants (Osterlund et al., 2000), 
whereas our data suggest that CSN is a negative regulator of SCF in fission yeast. Thus, 
e lucidation of the exact CSN function and its role in regulating various signal transduction and 
protein degradation pathways in different organisms will not be a trivial task to pursue. 
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Chapter 2. Human CULl forms an evolutionarily conserved ubiguitin 
li2ase complex (SCF) with SKPl and an F -box protein 
The data presented in this chapter were generated in collaboration with C. Correll and E. 
Kipreos (39). This work has been previously published (Lyapina et a t. , 1998; see Appendix I). 
Introduction 
The irreversible nature of proteolysis makes it well-suited to serve as a regulatory switch 
for control ling unidirectional processes. This principle is c learly evident in the organization of 
the cell division cycle, where initiation of DNA replication, chromosome segregation, and exit 
from mitosis are triggered by the destruction of key regulatory proteins ( 1-3). 
Proteins are typically marked for proteolytic degradation by attachment of multiubiquitin 
chains. This process is initiated by ubiquitin-activating enzyme (E I), which activates ubiquitin by 
adenylation and becomes linked to it via a thiolester bond. Ubiquitin is then transferred to a 
ubiquitin-conjugating enzyme, E2. Whereas E2s can directly attach ubiquitin to lysine residues 
in a substrate, most physiological ubiquitination reactions probably require a ubiquitin ligase, or 
E3 (4). E3s have been implicated in substrate recognition and, in one case, transfer ofubiquitin 
from E2 to a substrate via an E3-ubiquitin-thiolester intermediate (5). Once the substrate is 
multiubiquitinated, it is then recognized and degraded by the 26S proteasome. 
A novel ubiquitination pathway has recently been discovered in budding yeast. 
Components of this pathway include the CDC53, CDC4, and ySKPI gene products, which 
assemble into a ubiquitin ligase complex known as SCF (for .S.KP I, ~ullin , .E-box protein): since 
several of the yeast and human subunits have identical names, e.g., SKP I, we distinguish them 
with the letters y or h, respectively. SCF collaborates with the E2 enzyme yCDC34 to catalyze 
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ubiquitination of the CDK inhibitor SIC I. The specificity of SCF is thought to be governed by 
ySKPI and the F-box-containing subunit CDC4, which together form a substrate receptor that 
tethers SIC I to the complex. The assembly of this receptor is thought to be mediated by a direct 
interaction between ySKPI and the F-box sequences ofCDC4 (6, 7). 
Whereas genetic analysis has revealed that SIC I proteolysis requires CDC4, G I cyclin 
proteolysis appears to depend upon a distinct F-box-containing protein known as GRRI (8). 
Alternative SCF complexes (SCFGRRI) assembled with GRRI instead ofCDC4 bind G I cyclins 
but not SIC I , suggesting that there exist multiple SCF complexes in yeast whose substrate 
specificities are dictated by the identity of the F-box subunit (7). 
Components of the SCF ubiquitination pathway have been highly conserved during 
evolution. Human homologues ofyCDC34 and ySKPI have been reported (9, I 0), and F-box-
containing proteins like CDC4 and GRR I have been identified in many eukaryotes (II). Many of 
these F-box proteins also contain either WD-40 repeats (like CDC4) or leucine-rich repeats (like 
GRR I). A potential human counterpart ofGRR I, SKP2, has been identified along with hSKPI 
as a Cyclin A/CDK2-associated protein that is necessary for S-phase progression (I 0). 
Homologues ofCDC53, which are known as Cullins, are also present in many eukaryotes, 
including humans and nematodes ( 12, 13). 
Studies in budding yeast suggest that SCF substrates must be phosphorylated before they 
can be ubiquitinated ( 14, 15). Several human cell cycle regulators are targeted for ubiquitination 
following their phosphorylation by CDKs, implicating them as potential substrates ofSCF 
pathway(s) in human cells. Among them is the CDK inhibitor p27, the abundance of which may 
be regulated by CDC34-dependent ubiquitination (16, 17). In addition, Cyclins E and Dl are 
degraded by a ubiquitin-dependent pathway following phosphorylation at a specific site ( 18-20). 
The observation that Cyclin A/CDK2 associates preferentially with hSKPI and SKP2 in 
transformed cells to the exclusion of PCNA and p21 (I 0) raises the possibility that Cyclin A is 
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also a target of an SCF pathway. Alternatively, SCF-bound Cyclin A/CDK2 may phosphorylate 
SCF subunits or potential substrates such as E2F-I /DP-1 , thereby activating SCF-dependent 
ubiquitination (21, 22). 
Despite the conservation of SCF components from yeast to humans, several observations 
raise the question of whether the metazoan homologues are actually components of SCF-Iike 
ubiquitin ligases. First, whereas S.cerevisiae CDC 53'' mutants arrest at the G 1/S transition, 
C.elegans cul-l mutants fail to exit the cell cycle, resulting in hyperplas ia of most larval tissues 
( 12). It is unclear whether this discrepancy arises because cul-l and CDC53 have different 
functions, or because they are components of distinct ubiquitin ligase complexes with different 
substrate specificities. Second, the recent discovery ofubiquitin-like proteins (RUB I/NEDD8 
and SMT3/SUMO I) that are conjugated to proteins by pathways that involve E I and E2 
homologues (23) suggests that some homologues of SCF components might function in these 
alternative pathways. Indeed, attachment of RUB I to CDC53 fails to occur in skpl mutants, 
suggesting that ySKPI may be directly involved in the " rubinylation" ofCDC53 (24). Third, the 
best characterized human Cullin, CUL2, assembles with the von Hippei-Lindau tumor suppressor 
protein (VHL)/Eiongin B/Elongin C complex that has been suggested to regulate mRNA 
transcript elongation and accumulation of hypoxia-inducible mRNAs (25, 26). Forth, yeast SKP I 
assembles into a centromere-binding complex independent of its role in SCF, consistent with the 
possibility that vertebrate SCF subunits may serve as components of a variety of unrelated 
molecular machines. 
To address whether SCF-Iike activities are present in animal cells, we sought hCUL I 
binding partners, and we tested whether putative human SCF s ubunits can assemble together to 
y ield complexes with ubiquitin ligase activity. We report here that hCULJ is a direct functional 
homologue of CDC 53 since it can suppress the temperature-sensitive growth of CDC 53 mutants, 
associate with ubiquitin-conjugation activity in human cell lysates , and substitute for CDC53 in 
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the reconstitution of SIC I ubiquitination with purified components. Moreover, hCUL I directly 
binds to the putative SCF subunits hSKP I and SKP2. Taken together, these data provide strong 
evidence that an SCF-dependent ubiquitination pathway is conserved from yeast to mammals. 
Results 
Human CULl-interacting proteins. To identify human proteins that interact with 
hCUL I we performed a two-hybrid screen (30, 31 ). A full length hCULJ eDNA, fused to the 
LexA DNA-binding domain, was used as a bait to identify cDNAs from a HeLa library that 
encode hCULI interactors. This screen yielded clones encoding hSKPI, Protein Phosphatase 2A 
(PP2A) catalytic subunit, and the 20S proteasome subunit HsN3. None of these clones interacted 
with LexA-hCDK2 or LexA-Lamin C baits, suggesting that their interaction with LexA-hCUL I 
was specific. Here we examine in detail the interaction ofhCULI with hSKPI (see below). The 
physiological significance of hCUL I 's interaction with HsN3 and PP2A has not yet been 
evaluated. 
Human CULl interacts with hSKPl in vivo. The identification ofhSKPI as a hCULI-
interacting protein suggested that these proteins may be subunits of a complex in human cells that 
is similar to the SCF ubiquitin ligase of budding yeast. To test whether hCUL I interacts with 
hSKPI in vivo, we prepared affinity-purified rabbit polyclonal antibodies directed against theN-
and C-termini of hCUL I. Fig. I A shows specificity of the affinity purified antibodies. Both 
antibodies recognized one major polypeptide of - 80 kDa in transformed (HeLa S3) and non-
transformed (WI-38) cell lines (Fig. I A, lanes I, 2, 6, 7). This species comigrated with hCUL I 
produced in HiS cells infected with a baculovirus that contains full length hCULJ eDNA (Fig. 
I A, lanes 3 and 8). A more rapidly migrating species of recombinant hCULI detected in HiS 
cells by the anti-C-terminal antibodies (lane 3) presumably represents a breakdown product or 
initiation of translation downstream of the normal start codon, as this species was not detected by 
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the anti-N-tenninal antibodies. As expected, addition of a Polyoma antigen-hexahistidine tag to 
hCUL 1 (r11;56hCUL I) yielded a more slowly migrating hCUL I band (Fig. I A, lanes 4 and 9). 
Neither polyclonal antibody precipitated hCUL I from crude human cell lysates, 
precluding analysis of hCUL I complexes in non-transfected cells. Thus, to evaluate the potential 
interaction ofhCULI with hSKPI in vivo, we transfected HeLa S3 cells with Plli s6hCULI and 
11 AhSKP I expression vectors. Lysates were prepared from these cells 24 hr post-transfection and 
immunoprecipitated using cross-linked anti-Polyoma or anti-HA antibody beads. Proteins bound 
to the beads were separated by SDS-PAGE and analyzed by immunoblotting with anti-hCUL I 
and anti-HA antibodies (Fig. I B). Consistent with the two-hybrid data, hCUL I was specifically 
detected in hSKPI immunoprecipitates and vice versa. 
Human CULl, hSKPl, and SKP2 assemble into an SCF-Iike complex that can 
associate with Cyclin A/CDK2 kinase. Human SKPI was initially identified as a Cyclin 
A/CDK2-associated protein in transformed human cells (I 0). This association is mediated by 
SKP2, a human F-box protein with leucine-rich repeats, reminiscent ofthe GRRI protein. 
CDC53/Cullin and ySKPI, together with the F-box protein GRR I, constitute a putative SCF 
ubiquitin ligase complex that targets G I cyclins for degradation (6, 7). The homology of hSKP I, 
SKP2, and hCUL I proteins with components of the ySCF complex suggests that the human 
proteins may form a similar complex. We addressed this possibility by immunoprecipitating 
Pllis
6hCUL I from e5S]-Iabeled insect cells infected with baculoviruses that express Pllis6hCUL I ' 
hSKPI , and SKP2 (Fig. 2A); and by testing whether hCUL I can assemble with a previously-
described complex containing cyclin A/CDK2, hSKPI and SKP2 (Fig. 28). The interaction of 
hCULI with the cyclin A/CDKi 1A/hSKPI/SKP2 complex was monitored by 
immunoprecipitating CDKi 1A from [35S]-Iabeled insect cells infected with all five viruses in 
various combinations. As shown in Fig. 2A, Plli s6hCULI efficiently assembled with hSKPI and 
SKP2, suggesting that these proteins form a ternary complex similar to ySCF. Surprisingly, 
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hCULI interacted with cyclin A/CDK2 11 A complexes in the absence ofSKP2 or hSKPI (Fig. 2B, 
lane 6; note that hSKPI does not associate with Cyclin A/CDK2HA complex in the absence of 
SKP2). This may be due to either a direct interaction between hCUL I and cyclin A/CDKi 1A or 
the presence of a bridging protein in insect cells (e.g., see reference 6). Regardless, the ability of 
hCUL I expressed in insect cells to assemble into complexes containing a cyclin-dependent kinase 
is likely to be physiologically significant, since Pllis6hCUL I immunoprecipitates prepared from 
HeLa S3 cells contained histone HI kinase activity (data not shown). 
Human CULl directly interacts with hSKPl and SKP2. The results in Fig. 2 suggest 
that hCUL I, hSKP I, and SKP2 can assemble into an SCF-Iike particle when co-expressed in 
insect cells. Due to the strong conservation of SCF components, however, these interactions 
might be mediated by other proteins provided by the host cells (for an example see ref. 6). To 
test whether the observed interactions are direct, we produced GST-hSKPI, GST-SKP2, and 
MBP-hCUL I in bacteria. The GST fusions (or unfused GST control) were mixed with MBP-
hCUL I or MBP and recovered by binding to GSH-Sepharose beads. Bound proteins were 
resolved by SDS-PAGE and visualized by Coomassie Blue staining (Fig. 3). MBP-hCUL I, but 
not MBP, bound specifically and efficiently to GST-hSKPI and GST-SKP2, but not GST. This 
result demonstrates that hCULI can bind to both hSKPI and SKP2 without the participation of 
other proteins. 
Human CULl is functionally homologous to CDC53 and can form an active 
chimeric SCF complex with ySKPl and CDC4. The above observations indicate that hCUL I, 
the closest human homologue ofCDC53, can assemble with hSKPI and the F-box protein SKP2 
into a complex reminiscent of the yeast SCFGRRI complex. We next tested whether this complex 
-in the presence of hCDC34, E I enzyme and ubiquitin - was able to ubiquitinate proteins that 
e ither bind to it (cyclin A) (I 0), are known to be degraded inS phase (cyclin E, E2F-I) ( 18, 19, 
21, 22), or have been implicated as substrates of hCDC34 (p27) ( 16, 17). These efforts were 
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unsuccessful, raising the question of whether SCFSKP2 complexes possess ubiquitin ligase activity 
(data not shown). Moreover, ubiquitin ligase activity of the analogous yeast SCFGRRI complex 
has not been demonstrated yet, and might require additional unidentified components. However, 
we were able to address whether hCUL I is a functional component of a ubiquitin ligase complex 
genetically and biochemically by taking advantage of the considerable knowledge of this pathway 
in yeast. First, we asked if hCULJ can complement the CDC 53'' mutation. We introduced 
hCULJ and CDC53 under the control of the GALl promoter into a yeast strain carrying a 
temperature sensitive mutation in the CDC53 gene. Individual transformants were spotted at 
different dilutions on glucose (non-inducing conditions, data not shown) and galactose (inducing 
conditions) media at permissive (24°C) and restrictive (33°C) temperatures (Fig. 4). Only 
transformants that expressed wild type CDC53 or hCUL I proteins were able to grow at the 
restrictive temperature. However, hCULJ failed to complement a CDC53 null strain (data not 
shown). 
The ability ofhCUL I to complement the CDC53'' mutation implied that hCUL I can 
assemble into functional SCF complexes with yeast proteins. To test this idea we examined 
whether hCUL I can interact with the budding yeast SCF subunits ySKP I and CDC4. All three 
proteins were co-expressed in [35S]-methionine-radiolabeled insect cells in various combinations 
as indicated in Fig. 5. Human CUL I specifically co-precipitated with ySKPI 11A (Fig. 5A, lane 2) 
or PIIACDC4/ySKPI (Fig. 58, lane 4), indicating that it can form a chimeric SCFcoc4 complex 
with yeast proteins. 
Our previous findings identified SCFcoc4 as a functional E3 that required the presence of 
all three subunits (CDC4, CDC53, and ySKPI) to catalyze ubiquitination of phosphorylated SIC I 
(6, 7). Preceding its ubiquitination, phosphorylated SIC I is recruited to SCF coc4 by binding to 
the CDC4/ySKPI substrate receptor (6, 7). Given that hCULI and hSKPI assembled with CDC4 
(Fig. 58), we sought to test whether these hybrid SCF complexes were able to promote 
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ubiquitination of phosphorylated SIC I. Purified chimeric SCF complexes were incubated with 
M8P-SIC I Mlli sG and purified ubiquitination components. In the presence of SCFcoc4 (Fig. 6A, 
lane I), M8P-SIC I MHis6 was efficiently converted to high molecular weight forms. Omission of 
either CDC4, CDC53, or ySKPI resulted in no activity (Fig. 6A, lanes 2-4). Replacement of 
CDC53PIIA · h Pllis6hCULI I d · SCF I · h d b. . . . . . I w1t resu te 1n an comp ex w1t mo est u 1qllltlnat10n act1v1ty t 1at 
was dependent upon both CDC4 and ySKPI (lanes 5, 6, and 9). Additionally, an SCF complex 
containing both PHis6hCUL I and hSKPI along with PHACDC4 was also able to catalyze 
ubiquitination of M8P-SIC I Mllis6 (lane I 0). The conversion of M8P-SIC I to high molecular 
weight forms by hybrid CDC4/hCULI /hSKPI complexes required both substrate 
phosphorylation (Fig. 68, lane 5) and the presence of ubiquitin (Fig. 68, lane 6). Interestingly, 
co-expression of"11ACDC4, CDC53"11A, and hSKPI did not result in a functional SCF complex 
(Fig. 6A, lane 7). 
CDC53 was previously shown to interact with yCDC34 (32). Thus, we presumed that an 
SCF complex containing hCUL I would prefer to use hCDC34 as an E2 as opposed to yCDC34. 
However, SCFcoc4 complexes containing Pllis6hCULI with either ySKPI 11is6 or hSKPI appeared to 
work much more efficiently with yCDC34 than with hCDC34 serving as the E2 (Fig. 6C, lanes 3, 
4, 7, and 8). Although we do not understand the basis for this preference, it is possible that there 
exist additional human CDC34-like E2s that interact preferentially with hCUL !-containing 
complexes. Alternatively, the interaction between an F-box subunit and an E2 enzyme might also 
contribute to the specificity for a particular E2 (38). 
Human CULl assembles with ubiquitination-promoting activities in human cell 
extracts. The data presented so far are consistent with hCUL I functioning as a component of a 
ubiquitin ligase complex in human cells. Since we have failed so far to detect ubiquitination 
activity using recombinant hCULI /hSKP I /SKP2 complexes, we sought to develop an assay that 
would allow us to identify either substrates or cofactors of a hCUL !-dependent ubiquitination 
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pathway. Pllis6hCULI produced in insect cells in the presence or absence of hSKPI plus SKP2 
was bound to anti-Polyoma beads and incubated with crude HeLa S3 lysates to allow binding of 
other potential SCF components, regulators, and substrates. After washing away unbound 
proteins, E I, hCDC34, biotinylated ubiquitin, and an ATP-regenerating system were then added 
to the beads. Following an incubation, reactions were fractionated by SDS-PAGE, transferred to 
nitrocellulose, and blotted with streptavidin-HRP to detect ubiquitin conjugates. Whereas 
Phi'6hCULI or Phi '6hCULI/hSKPI/SKP2 complexes isolated from insect cells exhibited little 
ubiquitination activity (Fig. 7 A, lane 2 and Fig. 7B, lanes 3 and 4), a high molecular weight smear 
characteristic of ubiquitinated proteins appeared (Fig. 7 A, lane 3 and Fig. 7B, lanes 6 and 7) when 
these same components were preincubated with HeLa S3 lysate prior to the assay. In contrast, no 
signal was detected when naked polyoma beads were pre incubated with HeLa S3 lysate (Fig. 7 A, 
lane I). The appearance of slowly migrating biotinylated proteins depended on the addition of 
ubiquitin and ATP-regenerating system to the reaction (Fig. 7B, lanes 8 and 9), indicating that the 
high molecular weight smear was due to ubiquitination occurring during the in vitro incubation. 
Discussion 
Multiple homologues ofthe ySKPI, CDC53, and F-box subunits of the SCF ubiquitin 
ligase complex have been identified (10-13) and implicated in various cellular processes, 
including kinetochore function (33, 34), S-phase progression (10), exit from the cell cycle (12), 
transcript elongation, regulation of hypoxia-inducible genes, and suppression of tumorigenesis 
(25, 26). Based on the close homology between hCUL I and CDC53, we sought to address 
whether hCULI functions as part of an SCF-like ubiquitin ligase complex in human cells. A two-
hybrid screen to identify proteins that interact with hCUL I yielded hSKP I, suggesting that 
hCULI does indeed assemble into SCF-Iike complexes in human cells. Several other 
observations reported here support this hypothesis. First, hCULI associates with hSKPI 111 
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transfected HeLa S3 cells. Second, hCULI assembles into complexes with both hSKPI and the 
F-box protein SKP2 in vitro. Third, hCULI complements the growth defect of a CDC 53'' mutant. 
Fourth, hCULI and hSKPI can form chimeric SCF complexes with CDC4, and these complexes 
are able to ubiquitinate the SCFcoc4 substrate SIC I in vitro. Fifth, hCUL I associates with 
ubiquitination-promoting activity in HeLa S3 cell lysate. Taken together, these data strongly 
suggest that hCUL I is a subunit of an SCF-Iike E3 complex in human cells. 
What are the candidate substrates for hCULI-dependent ubiquitination in human cells? 
SIC I, CLN2, and FAR I must be phosphorylated before they can be ubiquitinated by the budding 
yeast SCF/CDC34 pathway (6, 7, 35). The stability of many mammalian regulatory proteins-
including IKBa, 13-catenin, p27, Cyclin D, and Cyclin E- is known to be controlled by 
phosphorylation (16-20, 36, 37). Further work will be required to determine whether any of these 
proteins are substrates for human SCF complexes. SCF-associated Cyclin A might also be a 
substrate of the SCFsKr2 pathway. This is less likely, though, since cyclin A is thought to be 
primarily destroyed via the APC/cyclosome pathway, and both cyclin A and SKP2 activities are 
essential for entry into S phase (10). Instead, the tight association ofcyclin A/CDK2 with SCF 
subunits both in vivo and in vitro might reflect an efficient coupling between substrate 
phosphorylation and ubiquitination in transformed cells. 
A study that complements our findings was reported by Lisztwan et al. (38). These 
authors demonstrated that hCUL I, hSKP I, and SKP2 assemble into a complex both in 
unperturbed and transfected human cells. Moreover, SKP2 was also shown to bind the ubiquitin-
conjugating enzyme hCDC34 in human cells, suggesting that SKP2 is part of an SCF-Iike 
ubiquitin ligase. SKP2 was also shown to associate with cyclin A/CDK2, and mutational analysis 
suggested that cyclin A/CDK2 binding might regulate SKP2/hSKPI but not SKP2/hCULI 
interaction in vivo. Our data support these findings and extend them by establishing that hCULI 
interacts directly with hSKPI and SKP2 without the participation of other eukaryotic proteins, 
so 
and hCULI and hSKPI can assemble into active ubiquitin ligase complexes either in insect cells 
or in HeLa S3 cell lysates. 
Further characterization of the SCF pathway in human cells will require the identification 
of functional F-box subunits and physiological substrates. The ability to stimulate the E3 activity 
of insect cell-derived hCUL I with HeLa S3 cell lysate provides a novel strategy for identifying 
these proteins. Moreover, this assay can be readily adapted to test whether the related hCUL2-
hCUL5 proteins also assemble into ubiquitin ligase complexes in human cells. Lastly, by 
converting either the chimeric SCF complex assay (Fig. 6) or the biotin-Ub-based assay (Fig. 7) 
to a microtiter plate format, it should be feasible to screen chemical libraries to identify 
compounds that modulate the activities of hSKP I and hCU L I. Given its critical role in cell 
division in budding yeast, inhibitors ofSCF might be valuable lead compounds for the 
development of novel anti-cancer chemotherapeutics. 
Experimental Procedures 
Yeast strains and reagents. Yeast strains, plasmids, and a HeLa eDNA library for the two-
hybrid screen were a generous gift from R. Brent (Massachusetts General Hospital, Boston, MA). 
Wx 131.2c CDC53-2'' strain was obtained from M. Goebl (Indiana University, Indianapolis, IN). 
Baculoviruses expressing hCDK211A , hCyclin A (D. Morgan, UCSF, San Francisco, CA), SKP2 
(H. Zhang, Yale, New Haven, CT), hSKPI (P. Sorger, MIT, Cambridge, MA) and plasmids 
pGEX-KG-hSKPI , pGEX-KG-SKP2 (P. Jackson, Stanford, Palo Alto, CA), pCS2+n~gal, 
pCS2+SMC I (S. Handeli , FHCRC, Seattle, WA) were kindly provided by the indicated 
investigators. Other baculoviruses were previously described (6). Ubiquitin and the Protein 
Biotinylation Kit were purchased from Sigma, and biotinylated ubiquitin was prepared according 
to the manufacturer's instructions. Ubiquitin aldehyde was a generous gift from R. Cohen 
(University of Iowa, Iowa City, Iowa). 
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Plasmid and baculovirus construction. Full length hCUL I ORF was assembled from ESTs 
HE2AB96 and HSVAD74 and subcloned into pRS316 and pMALc (New England Biolabs). The 
same hCUL I fragment was also subcloned into pYL 1393 (PharMingen) to generate a hCUL !-
expressing baculovirus. AnN-terminal epitope-tagged version of hCUL I was constructed by 
inserting a DNA cassette that contains two tandem repeats ofthe Polyoma epitope (MEYMPME) 
followed by six histidine residues (designated as PHis6) into pRS316-hCUL I. PJJis6hCUL I 
fragment was then subcloned into pFASTBAC I (Gibco BRL) to generate a PJJis6hCUL I 
baculovirus, and pDNA3.1 /Zeo (Invitrogen) to generate pcDNA3.1-PHis6-hCUL I. pCS2+HA-
hSKPI was generated by subcloning a hSKPI fragment from pGEX-KG-hSKPI into pCS2+HA. 
Antibodies. Anti-hCUL I antibodies were generated in rabbits immunized with either a fusion 
protein containing the first 41 residues of hCUL I followed by GST (BAbCO), or a fusion protein 
containing GST followed by the last 86 residues ofhCUL I (Caltech antibody facility). 
Antibodies against hCUL I and GST were affinity purified using MBP fusions of the 
corresponding peptides and GST, respectively, as described (27). Monoclonal anti-Polyoma 
antibodies were bound to protein A-Sepharose beads and cross-linked to protein A with 
dimethylpimilimadate (27) at a concentration of approximately 2 mg of antibodies per ml of 
protein A resin. Anti-HA resin was generated by coupling I ml ofanti-HA ascites to I ml of 
CNBr activated agarose (Pharmacia Biotech) according to the manufacturer's protocol. 
Expression and purification of proteins. Proteins expressed in bacteria or yeast were purified 
according to standard protocols and as described (6). For the expression and purification of 
chimeric SCF complexes, HiS insect cells were infected with baculoviruses expressing PHACDC4 
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(PHA designates an epitope-tag consisting of two tandem repeats of the Polyoma epitope 
followed by three hemagglutinin epitopes), CDC53PIIA' Pllis6hCULI (MO!s of6), ySKP I11;56, or 
hSKPI (MOis of 4) as indicated in the results. Seventy-two hours post-infection, cells were 
collected and lysates were prepared as described (6) . The Polyoma tagged proteins were affinity-
purified from these lysates (6) to yie ld the various SCF complexes. 
Cell cultures and transfections. Wl-38 human lung fibroblasts were purchased from ATCC. 
HeLa S3 cells were a gift from S. Handeli (FHCRC, Seattle, WA). Cells were grown in OM EM-
F 12 (Gibco BRL) supplemented with I 0% FBS (Gibco BRL) at 37°C/5%C02. Cells were 
transfected in I 00 mm dishes by the modified calcium phosphate method (28). I 0 J.!g pCS2+ HA-
hSKPI and 7.5 J.!g pcDNA3.1-PHis6-hCULI vectors were used per transfection plate. 
Transfection efficiency was monitored by co-transfection of 2.5 J.!g pCS2+n~gal plasmid per 
transfection plate followed by standard colorimetric ~gal assays (29). Total DNA concentration 
was 20 J.!g/ 1 00 mm dish and was adjusted for every transfection plate by addi ng empty vectors. 
Cells were harvested and lysed 24 hr post-transfection. 
Immunoprecipitations and Western blotting. Baculovirus-infected insect cells were harvested 
and lysed at 48 hr (for Sf9 cells) or 72 hr (for HiS cells) post-infection in 0.8 ml of lysis buffer per 
I 00 mm plate (as described in ref. 6). Metabolic labeling was done by incubating insect cells for 
3 hr in methionine-deficient medium plus 20 J.!Ci/ml ofTranC5S]-Iabe l prior to lysis. Wl-38 and 
HeLa S3 cells were lysed in 0.4 ml of lysis buffer per I 00 mm plate. Lysates were cleared by 
centrifugation at 14,000g for 15 min, adjusted to I 0% glycerol, frozen in liquid nitrogen, and 
stored at -80°C. Cell lysates (I mg) were incubated with 50 J.!l of antibody-coupled beads (I: I 
suspension in lysis buffer) for 2 hr at 4°C. Precipitates were washed five times with I ml of lysis 
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buffer and analyzed by SDS-PAGE followed by Western blotting or autoradiography. Western 
blotting was performed as described (27). Ptios6hCULI and 11AhSKPI were detected by rabbit 
polyclonal anti-hCUL I and biotinylated anti-HA ( 12CA5) primary antibodies and visualized by 
incubation with goat anti-rabbit-HRP and streptavidin-HRP conjugates, followed by ECL 
detection (Amersham). 
Ubiquitination reactions. Crude Sf9 celllysates (500 IJ.g) prepared from cells infected with 
"'"s6hCUL I baculovirus were incubated with 20 IJ.I anti-Polyoma beads for 2 hr at 4°C to allow 
"'"s6hCULI binding. Beads were washed three times with lysis buffer and incubated with I mg of 
crude HeLa S3 lysate overnight at 4°C. Beads were then washed three times with lysis buffer and 
supplemented with 61J.g biotinylated ubiquitin (BUb), 500 ng hCDC34, 25 ng llis6yUBA I, I IJ.I of 
I OX ATP-regenerating system (6), I IJ.I of I OX reaction buffer (6), and 0.5 11M ubiquitin 
aldehyde. Reactions were adjusted to I 0 IJ.I by adding 20 mM HEPES [pH 7.6] , I 00 mM KOAc, 
I mM OTT, incubated for 90 min at 30°C, and terminated by adding Laemmli sample buffer. 
Samples were analysed by Western blotting with streptavidin-HRP conjugate. Allubiquitination 
reactions with chimeric SCF complexes were performed as described (6). 
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Figure 1. Human CULl and hSKPI interact in vivo. (A) hCULI detection by affinity purified 
anti-hCUL I antibodies. 50 j.!g of crude human cell lysates (lane I, 2, 6, and 7) and 0.5 j.!g of 
crude lysates from HiS insect cells, uninfected (lanes 5 and 10) or infected with hCULI (lanes 3 
and 8) or Pllis6hCUL I (lanes 4 and 9) viruses, were resolved on an 8% SDS-polyacrylamide gel, 
transferred to a PVDF membrane, and probed with anti-hCUL I antibodies. 04: serum raised 
against C-terminal part of hCUL I; N I: serum raised against N-terminal part of hCUL I. Asterisk 
designates putative N-terminally truncated hCUL I that is recognized by C-terminal antibody. (B) 
HeLa S3 ce lls were transfected with pcDNA3.1-PHis6-hCUL I (lanes I, 4, and 7), pCS2+HA-
hSKP I (lanes 3, 6, and 9), or both plasm ids (lanes 2, 5, and 8). Lysates ( I mg) were prepared 24 
hr post-transfection and immunoprecipitated with anti-Polyoma (lanes 4-6) or anti-HA (lanes 7-9) 
beads. Proteins retained on the beads were analyzed by Western blotting. Lanes 1-3 contained 
20 jl.g of crude lysate. 
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Figure 2. Human CUL I can interact with human SKPI, SKP2, and Cyclin A/CDK2. Sf9 insect 
cells were infected with baculovirus constructs that express various human proteins as indicated. 
Cells were labeled with Trane5S)-Iabel for 3 hr prior to harvesting. Plli s6hCUL I (panel A) and 
11AhCDK2 (panel B) together with associated proteins were immunoprecipitated by anti-Polyoma 
and anti-HA beads respectively. The composition of the protein complexes in the 
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Figure 3. Human CUL I binds directly to hSKPI and SKP2. MBP, MBP-hCUL I, GST, GST-
hSKPI , and GST-SKP2 were individually expressed in and purified from bacteria. Each protein 
was present in the binding reactions at 65 J.lg/ml. 4 J.lg of each protein were loaded in lanes 1-5, 
which represents 1/5 of the input for the binding reactions. Proteins were mixed as indicated 
(lanes 6-1 0) and incubated on ice for I hr. GST and GST fusions were collected on GSH-
Sepharose for I hr at 4°C. Proteins bound to GSH-Sepharose were resolved by SDS-PAGE and 
visualized by staining with Coomassie Blue. Positions of the full length fusion proteins are 
indicated by the arrows. An - 70 kDa band that copurified with GST-SKP2 from bacteria is 
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Figure 4. hCULJ complements the CDC5f' mutant phenotype. A CDC53-f' mutant strain was 
transformed with pTS 161-CDC53 and pTS 161-hCUL I plasm ids that allow controlled expression 
of CDC 53 and hCUL I from the galactose-inducible GALl promoter. Empty vector alone was 
used as a negative control. Ten-fold serial dilutions of the individual transform ants were spotted 
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Figure 5. Human CULl can interact with yeast SCF components ySKPI and CDC4. HiS insect 
ce ll s were infected with baculovirus constructs expressing various proteins as indicated. Cel ls 
were labeled with TranC5S]-label for 3 hr prior to harvesting. Yeast SKP 111A (panel A) and 
PIIACDC4 (panel B) together with associated proteins were immunoprecipitated by anti-HA and 
anti-Polyoma beads, respectively. The composition of the protein complexes in the 
immunoprecipitates was analyzed by SDS-PAGE fo llowed by autoradiography. The asterisk 
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Figure 6. SICI is ubiquitinated by chimeric SCF complexes. (A) Hi5 insect cel ls were infected 
with various baculoviruses expressing PHACDC4, CDC53PIIA (53), "11156hCUL I (C), ySKP I His6 (Y), 
or hSKPI (H) as indicated. At 72 hr post-infection, lysates were prepared and SCF complexes 
were affinity purified on an anti-Polyoma matrix, and eluted complexes were incubated for 2 hr at 
25°C in the presence ofMBP-SICIMIIis6 and purified ubiquitination components (see Materials 
and Methods). At the end of the incubation the samples were fractionated by SDS-PAGE and 
immunoblotted with anti-Myc antibodies to detect MBP-SIC I Mllis6. Bound antibodies were 
visuali zed by ECL. (B) The indicated SCF complexes were purified from baculovirus-infected 
insect cell lysates and incubated with the full set of ubiquitination components (lanes I and 4), or 
in the absence ofCLN2/GST-CDC2811A/CKSI (lanes 2 and 5) or ubiquitin ( lanes 3 and 6). (C) 
Purified SCF complexes containing CDC53"11A (53), Pllis6hCUL I (CUL I), ySKP 111156 (Y), or 
hSKP I (H) subunits were incubated with ubiquitination components containing either yCDC34 
(Y) or hCDC34 (H). 
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Figure 7. Human CUL 1 associates with ubiquitination activity in He La SJ lysates. (A) Anti-
Polyoma beads were incubated in the presence of PHis6 hCUL 1, He La SJ lysates, or both as 
indicated, washed five times with lysis buffer, and mixed with the ubiquitination reaction 
components (reaction mix): His6yUBA I, hCDC34, biotinylated ubiquitin (BUb), and ATP-
regeneration system (ARS). Incorporation ofbiotinylated ubiquitin into proteins present in the 
reactions was monitored by probing with streptavidin-I-IRP conjugate followed by ECL detection. 
(B) Plli s6hCUL 1 alone, or together with hSKPI and SKP2, was produced in insect cells and bound 
to anti-Polyoma beads that were then washed and incubated at 4°C in the presence or absence of 
crude HeLa SJ lysates to allow bead 'activation'. ' Activated ' beads were then treated as in panel 
A. Dependence on the presence of ATP and BUb in the reactions was determined by omitting 
these components from the reaction mix (lanes 5, 8 and 9, respectively). The entire reaction mix 
was omitted in lane 10. Lane 1 contained reaction mix only. P-BUbn designates a ladder of 
ubiquitinated proteins produced in the reaction. 
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Chapter 3. COP9 Si~:nalosome Binds Cullin Ubiguitin Li~:ases And 
Re~:ulates Cullin Neddylation 
The data presented in this c hapter were generated in collabo ration with G. Cope, A. 
Shevchenko, D. Wo lf, and A. Shevchenko. This work has been submitted fo r publication. 
Introduction 
Human CULl is a me mber of the Cullin prote in family (Kipreos et a t. , 1996). All known 
Cull ins bind RING-H2 finger prote ins HRTI and HRT2 (Ohta et a t. , 1999), are modified by 
covalent attachme nt of a ubiquitin- li ke protein NEDD8/RUB I (Hori et a t. , 1999), and are 
confi rmed or likely components of multi-subuni t ubiquitin ligases. CULl -based SCF ubiqu itin 
ligases cons ist of at least four subunits: CULl and HRTI , which harbor a core ubiquitin ligase 
activity, a variable F-box protein serving as a substrate receptor, and SKPI , linking the two 
modules together. The two best studied mamma lian SCF complexes, SCF5K 1' 2 and SCFi3TrCP target 
p27 (Carrano et a t., 1999) and IK.Ba, ~-catenin (Winston et a t. , 1999) for ubiquitin-depende nt 
degradatio n, respectively. A ll known SCF substrates need to be phosphorylated be fore they can 
be recognized by the F-box receptor subuni t. Thus it is thought that ubiquitination of prote ins by 
SCF is regulated on the level of substrate phosphorylation (Deshaies, 1999). Additio na lly, SCF 
acti vity is stimulated by attachment of the ubiquitin-like protein NEDD8 (i.e. , neddylation) to 
CUL I (Osaka et a t. , 2000). It is not known if there are other fo rms of SCF regulation at play, or 
if there are additional SCF subunits yet to be discovered . 
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Results 
In order to address these questions we constructed retroviral vectors that expressed Myc9-
TEV -tagged forms of the human F-box protein SKP2 and C-terminally truncated human CULl 
(~692-752) and used them to infect mouse NIH 3T3 cells. SCF complexes were purified from 
these cells on anti-Myc beads, eluted with TEV protease (the tagged proteins were linked to Myc9 
by a recognition site for the Tobacco Etch Virus (TEV) protease; Seol et al. 200 I), resolved by 
SDS-PAGE, and silver stained (Fig. I). Bands corresponding to specific interacting proteins were 
excised from silver stained gels and analyzed by MALDI and Nano electrospray tandem mass 
spectrometry as described previously (Seol et al., 1999; Shevchenko et al., 1996). 
SKP2 eluates (Fig.l, lane 2) contained SCF subunits, CUL I and SKP I, which were 
previously known to interact with SKP2 (Lyapina et al., 1998). We also identified a mouse 
homologue of yeast SGT I, previously reported to bind ySKP I and have an essential but 
undefined role in kinetochore function and turnover of SCF substrates (Kitagawa et al., 1999). 
SGTI is likely to be an SCF component or a regulator of SCF function. Surprisingly, we have 
also identified relatively high amounts of CKS I in the SKP2 eluates. CKS I binds and activates 
cyclin dependent kinases (Reynard et al., 2000). Although we did find CDC2 in SKP2 eluates, 
the small amount of the kinase present could not account for the high amount of CKS I in the IP, 
thus CKS I could only be brought down through binding to SKPI or SKP2. Since there was no 
CKS I in the CUL I IP (Fig. I, lane 3) which contained an equivalent amount of SKP I, it is most 
likely that CKS I binds directly to SKP2 and is a bona fide stochiometric subunit of SCFsKPz 
complexes. 
Analysis of CULI~C eluates (Fig. I, lane 3) also revealed specific binding of SCF 
subunits, SKP I, HRT I, and a number ofF-box proteins, as expected. Elongation Factor 2 (EF-2) 
was also present in the IP, but the significance of this interaction is unclear. Unexpectedly, the 
other non-SCF proteins associated with CULl ~C turned out to be all eight subunits of the COP9 
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Signa losome (which has recently been renamed CSN (Deng et a l. , 2000)). CSN is an e ight-
subunit complex of about 450-500 kDa that was originally discovered in Arabidopsis rhaliana as 
a suppressor of photomorphogenesis (Wei and Deng, 1998). CSN subunits have significant 
sequence homologies with components of the lid subunits of the 19S regulator of the 26S 
proteasome (Seeger et al., 1998) and with the translational initiation complex eiF3 (Glickman et 
a\. , 1998), but the biochemical function of CSN remains elusive. 
In plants, CSN positi vely regulates COP I, a protein wi th anN-terminal RING-HC finger 
domain, a coiled-coil motif, and a C-terminal WD40 repeat domain that directly binds to the Hy5 
transcription factor, responsible for the activation of light-inducible gene transcription 
(Chattopadhyay et al., 1998; Oyama et al., 1997). COP I is thought to target Hy5 fo r degradation 
in the dark, and CSN regulates COP! function and cellular locali zation by either promoting 
COP I import into the nuc leus or inhibiting its export from the nuc leus (Chamovitz et al., 1996). 
S ince we identified COP9 Signalosome in the IP of a C-terminally truncated CUL I that 
lacks the neddylation site, we first wanted to test if full length CUL I can also interact with CSN. 
We transfected HeLa cells with constructs that expressed, Myc9-tagged full length and truncated 
CULl , immunopurified CULl from these cells using anti-Myc beads, and probed 
immunoprecipitates with anti-CSN8 antibodies and anti-SKPI antibodies as a positive control 
(Fig. 2). Equal amounts of CSN8 and SKPI, which is known to bind to the N-tenninus of CULl 
(Miche l and Xiong, 1998), (Fig. 2, lanes 2 and 3) were assoc iated with both forms of CUL I, 
suggesting that the C-terminus of Cullin and its neddylation are dispensable for binding to CSN. 
Next, we tested if other SCF subunits and other Cullins can a lso bind to the CSN. We 
transfected Flag-tagged CSN I into HeLa cells and purified CSN complex using anti-Flag beads 
(Sigma). CSN I and associated proteins were e luted with Flag peptide and analyzed by SDS-
PAGE and Western blotting (Fig. 3). As expected, CSN8, a subunit of Signalosome, was present 
in the e luate, confirming that we were pulling down CSN complexes and not a non-functiona l 
monomeric form of Flag-CSN I. Blotting with antibodies against human Cullins 1-3 revealed that 
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a ll of them bind CSN. Other data suggest that CUL4a and CUL5 can interact with CSN subunits 
as well (S. Schwartz, personal communication). 
If CUL I bound to CSN as part of SCF complexes, other SCF components should also be 
present in the Signalosome IPs. Indeed, we found HRTI , SKPI, and the F-box protein SKP2 in 
F lag-CSN I e luates. We also found a slower migrating modified (perhaps, phosphorylated) form 
of an SCF substrate, IKBa, present in the CSN e luates, consistent with the notion that it was 
associated with CSN via its binding to SCF. Thus, all Cullins seem to assoc iate with CSN in the 
context of respective ubiquitin ligase components and, possibly, substrates. What is the 
significance of this association? Since all Cullins bind to Signalosome, it is unlike ly that CSN is 
regulated by associated Cu llin ubiquitin ligases. Rather, since CSN was previous ly implicated in 
functioning downstream of various s ignal transduction cascades, Signalosome might be a g lobal 
integrator of signaling pathways that radiates its outputs onto various assoc iated ubiquitin ligases 
to activate or repress their acti vity. 
Since we observed the presence of an SCF substrate in CSN I IPs, we wanted to test if 
CSN perturbations have any effect on the stability of SCF substrates, particularly, IKBa. TNFa 
stimulation of HeLa cells leads to a rapid activation of IKBa kinase (IKK) and IKBa 
phosphorylation, which, in turn, triggers IKBa ubiquitination by SCFI3TrCP and degradation by 26S 
proteasome (Fig. 4 (A), lanes I and 2). Treatment of these cells with a proteasome inhibitor 
LLnL prevents IKBa degradation and leads to its accumulation as a phosphorylated intermediate 
(Fig. 4 (A), lane 3). Overexpression of a dominant negative form of ~TrCP, lacking the F-box 
(~TrCPL'lF), similarly leads to IKBa accumulation in a phosphoshifted form (Fig. 4 (A), lane 6). 
Surprisingly, overexpression of CSN I also prevented TNFa inducible degradation of 
IKBa; however, IKBa accumu lated in a non-phosphorylated form in these cells (Fig. 4 (A), lane 
8). This can be a result of e ither lower IKK activi ty or inc reased phosphatase 
activity/IKBa accessibility to the phosphatase in CSN I overexpressing cells. Treatment with a 
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prote in phosphatase inhibitor Calyculin A prevents IK.Ba dephosphorylation by PP2A 
phosphatase and mimics TNFa induced IK.Ba degradation due to low levels of acti ve IKK in 
uninduced cells (Fig. 4 (A), lane 5). Treatment of CSN I overexpressing cells with both TNFa 
and Calyculin A led to IK.Ba stabilization in a phosphorylated form, suggesting that CSN I 
overexpres ion does not prevent IKK activation in response to TNFa, but, instead, influences 
some other step in the IK.Ba degradation pathway (Fig. 5). Pre liminary data suggest that IKK 
activ ity is similar in TNFa induced cells with or without CSN I overexpression (data not shown). 
CSN might a lso function as a scaffold, bringing IKK, its substrates, and SCF in c lose prox imi ty 
to each other, facilitating ubiquitin-mediated substrate proteolys is. We tested if IKK was 
associated with CSN (Fig. 4 (B)). We observed that IKK, as we ll as wt and phosphomutant forms 
of IK.Ba were able to bind CSN independent of each othe r (Fig. 4 (B), lanes 1-5), consistent with 
the above hypothesis. 
Although previous studies suggested that CSN I overexpression leads to a gain of 
function phenotype in A. thaliana (Kang et al. , 2000), we could not conclusively dete rmine 
whether CSN was acting as a positi ve o r negative regulato r of the SCF pathway in our 
transfecti on experiments. To find out in more detail how Signalosome might regulate SCF 
acti vity, we turned to a unicellular eukaryote Schizosaccharomyces pombe, where we could 
address the problem using genetic techniques. Unlike budding yeast S. cerevisiae, which doesn't 
appear to have the CSN complex, except fo r a CSN5(JAB I) homologue, fi ssion yeast S. porn be 
appears to conta in a full CSN complex, and a fi ss ion yeast CSN I homologue, Caa I, is required 
fo r proper S phase progress ion (Mundt et a l. , 1999). First, we sought to confirm that the fi ss ion 
yeast CUL I homologue, Pcul , inte racts with S. pombe S ignalosome. Strains whose pcul and 
caal chromosomal loci were modified to encode proteins tagged with multimerized Myc 
epitopes were transformed with a plasmid that expressed HA-tagged CSN2 homologue (Sgn211 A) 
from an induc ible plasmid to test if we can detect Pcu I Myc interaction with Sgn211A. Anti -Myc 
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i mmunoprecipitates prepared from caal myc 13+ cells (but not those from untagged strains) 
contained Sgn211A (Fig. 6 (A), lane 7), as expected. Similarly, Sgn211A was selectively recovered 
in anti-Myc precipitates from pculmyc/3+ cells (Fig. 6 (A), lane 8), indicating that Cullin/CSN 
interaction is evolutionarily conserved. Interaction of Pcu I with S. pombe CSN was evaluated 
further by probing Caa I Myc and Sgn211A immunoprecipitates with anti-Pcu I antibodies. As can be 
seen from Fig. 6 (B), endogenous Pcu I could be detected in Sgn2HA IPs (lane 6), confirming our 
earlier notion. Our failure to detect Pcu I associated with Caa I may stem from effects of the Myc 
epitope tag on Caa I. Taken together, these observations suggest that the interaction of CSN with 
SCF is conserved from yeast to human cells. 
To investigate the role of CSN in SCF function we analyzed SCF components in t1caal 
cells (Mundt et al., 1999). Interestingly, endogenous Pcu I accumulated in a modified form (Fig. 
7 (A), lane 2) in t1caal strain, but not other mutants that, simi tar to t1caa I, have a high proportion 
of cells accumulating in S phase (lanes 5-7), as well as F-box protein deletion mutants t1pop I and 
t1pop2 (lanes 3, 4), suggesting that Pcu I modification did not result from an abnormal cell cycle 
position of the t1caal mutant cells. S. pombe Pcu I is modified on Lys 713 by covalent 
attachment of Nedd8 in vivo (Osaka et al., 2000). We reasoned that the altered migration we 
observed could result from increased neddylation. To test this hypothesis, we introduced 
plasmids that expressed wt and K713R Pcu I Myc (Osaka et al. , 2000) into caal+ and t1caal strains 
and analyzed extracts from these cells by Western blotting with anti-Myc antibodies (Fig. 7 (B)). 
The K713R mutation completely abolished Pcu I modification observed in t1caal cells (compare 
lanes 3 and 4), suggesting that slower migrating Pcu I forms are indeed neddylated Pcu I. We also 
immunopurified endogenous Pcu I from wt and t1caal cells transformed with a plasmid that 
expressed HArtagged Brassica napus Nedd8 (Fig. 7 (C)). Higher amounts of Nedd8 11A3 were 
detected in Pcu I IPs from t1caal cells than from wt cells (Fig. 7 (C), lanes 7 and 8, bottom 
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panel), confirming that Pcu I neddylation is increased in !!.caal cells. C learly, functional 
Signalosome might be required for Pcu I deneddylation or repression of Pcu I neddylation. 
How does increased neddylation of Pcu I in !!.caal cells affect SCF function? First, we 
tested the integrity of SCF complexes in !!.caal strain. The prote in levels of Pcu I , the SKP I 
homologue Psh I and the HRT I ho mologue Pip I (Fig. 8 (A and B)) were unaffected in !!.caa I 
cells. Psh I and Pip I binding to Pcu I in wt and !!.caal cells was indistinguishable as well (Fig. 8 
(B)). Si nce it has been previously noted that neddylation acti vates SCF acti vity (Osaka et a l. , 
2000), we tested if ubiquitin ligase activity of SCF complexes in !!.caa l cells was increased (Fig. 
8 (C)). Two independent ubiquitin incorporation assays with SCF complexes from Pcu I M yc l3 
tagged strains (lanes 1-3) o r SCF complexes purified using anti-Pcu I antibodies from untagged 
strains ( lanes 4-6) revea led that SCF ubiquitin ligation activity is 2-4 fold higher in !!.caal strain 
compared wi th the wt (lane 2 vs. 3, and lane 5 vs. 6). However, we did not observe any change in 
the half-life of the SCF substrate Rum I in !!.caa I strains (data not shown), perhaps because 
substrate phosphorylation, and not SCF activity, is the limiting step that determines the kinetics of 
Rum I degradation. 
Because Nedd8 is stro ng ly enriched in the nucleus (Kamitani et a l. , 1997), and CUL I 
must be imported into the nuc leus to be neddylated (Furukawa et al. , 2000), increased Pcu I 
modification might be an indirect result of increased nuclear loca li zation of Pcu I. Additionally, 
increased neddylation might lead to a redistribution of Pcu I antigen within the cell, as it has been 
reported that neddylated CULl is enriched at the kinetochores (Freed et al., 1999). We looked at 
Pcu I M yc l3 loca li zatio n in wt and !!.caa l strains carrying chromosomally tagged Pcu I by indirect 
immunofluorescence (Fig. 8 (D)), but we did not observe any noticeable changes in Pcu I 
locali zation. We a lso looked at endogenous untagged Pcu I locali zation by bioche mical 
fractionation (Fig. 8 (E)). While cytoplasmic enzyme Pycl was found exclusively in the 
cytoplasm, and a nuc lear protein Mcm5 was found exclusively in the nucleus, Pcu I was found 
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both in the nucleus and cytoplasm in all stra ins tested, confirming our immunofluorescence 
loca lization data. 
Because increased neddylation of Pcu I was the only obvious effect of the 11caa l 
mutation on SCF, we reasoned that CSN might govern the ba lance of neddylating and 
deneddylating activities in S. pomhe. Neddylation is reminiscent of ubiquitination and is 
mediated by the two-subunit E l -like enzyme, Ula i!Uba3, and the E2- li ke enzyme Ubc l2. A ll 
components of neddylation pathway are essential in S. pombe (Osaka et al. , 2000). Although a 
variety of deubiquitinating enzymes has been described, no NEDD8-specific proteases have been 
discovered yet. However, UCH-L3, which was originally identified as a ubiquitin-specific 
hydro lase, was found to possess NEDD8 C-tenninal hydrolase acti vity (Wada et a l. , 1998). 
S imila rly, a novel UBP, USP2 1, capable of deconjugating ubiquitin from ubiquitinated prote ins, 
was shown to be capable of removing NEDD8 from NEDD8 conjugates (Gong et a l., 2000). 
We reasoned that Pcu I hypemeddylated state in 11caa / cells could result from either 
inc reased neddylating acti vity o r a decreased deneddylating acti vity in L1caa / cells. To determine 
whether inc reased accumulation of Pcu I-Nedd8 conjugates in Llcaa l cells was due to g lobal 
de regulation of neddylation, caa l + and Llcaa l cells were transformed with a plasmid that 
expressed 11 A 3Nedd8, and anti -HA immunoprecipitates prepared from these cells were 
immunoblotted with anti-HA to evaluate the pattern ofNedd8-modi fied proteins (Fig. 7 (D)). 
Whereas little s ignal was detected in immunoprecipitates prepared from caa l + cells (lane 3), 
multiple 11 A 3Nedd8-modified prote ins were detected in immunoprecipitates from 11caa l cells ( lane 
4), suggesting that loss of CSN function leads to enhanced neddylation of multiple substrates. 
Next we sought to determine whether the global hyperneddylation that occurred in 11caa l cells 
was due to accumulation of an inhibitor of deneddylation present in Llcaa l extracts (a dominant 
activity with respect to wt cells) or a loss of deneddylating enzyme acti vity (a recessive acti vity). 
To discriminate between these possibili ties, we prepared extracts from tagged caa l + pculmyc!Y 
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and untagged pcu I + !Jcaa l strains, incubated them in the absence o f ATP (to prevent de-novo 
neddylation), and followed the neddylation state of the endogenous untagged Pcul from !Jcaa l 
extracts by Western blotting (Fig. I 0 (A, B)). Incubation with wt extracts led to an almost I 00% 
convers io n of fully neddylated Pcul form !Jcaa l extracts into an unmodified form , sugges ting 
that there is a de fi c it of deneddylating acti vity in !Jcaa l cells (lanes I and 2). 
We purified CSN fro m pig spleen to test its biochemical acti vity in vitro (Fig. 9 (A and 
B)). Re markably, purified CSN (Fig. 10 (A)) could restore deneddly lating acti vity to !Jcaa l 
extract (lane 3), suggesting that Signalosome either stimulated a cryptic deneddylating enzyme in 
!Jcaa I cell extract or itself harbored a deneddylating acti vity. The latter possibility was strong ly 
suppo rted by the observation that purified pig spleen CSN deneddylated Pcu I Mycn that was first 
immunopurified fro m !Jcaa l extract (Fig . I 0 (C)). Deneddylating activity might either be 
provided by one of the CSN subunits or by a tightly associated deneddylating enzyme. 
Interesting ly, CSNS (JAB I ) orthologs contain an invariant cyste ine which is fl anked by a highly 
conserved sequence with similariti es to the active site "Cys box" seen in many deubiquitinating 
enzymes (Glickman et al., 1998) (Fig. I 0 (E)). Furthe rmore, the deneddylating acti vity of 
purified CSN was obliterated by pre incubation with the sulfhydryl agent N-ethylmale imide (Fig. 
I 0 (B), lanes 4 and 5). We reasoned that CSNS/JAB I and its ho mologues from othe r species 
might define a new class of deneddylating enzymes, potentia lly accounting for the deneddylating 
acti vity detected in the purified S ignalosome preparations. 
Discussion 
Our findings provide the first c lear ins ight into the biochemical function of the CSN. The 
best understanding o f CSN function comes from its ro le in controlling photomorphogenesis in 
plants. In darkness, the putative ubiquitin ligase COP I enables rapid turnover o f the 
transcriptiona l regulator HyS. In seedlings exposed to light or in CSN mutants, COP I 
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redistributes to the cytoplasm, allowing Hy5 to accumulate and promote transcription of 
photomorphogenetic genes. It has been proposed that CSN regulates photomorphogenesis by 
governing the nucleocytoplasmic distribution of COP I. We argue instead that CSN controls 
COP I -mediated turnover of Hy5 by modulating the neddylation of COP I, Hy5, or an affiliated 
protein, with redistribution of COP I to the cytoplasm occurring in response to the accumulation 
of Nedd8 conjugates. It will be interesting to see how light impinges on the CSN-dependent 
activation of COP I , and whether a similar circuit involving CSN regulates light-entrained 
behaviors in animals. 
Intriguingly, the catalytic CSN5/JAB I subunit is the only CSN subunit that is found both 
in monomeric and complexed forms (Kwok et al., 1998). Moreover, it is the only subunit of CSN 
found in S. cerevisiae, and mutants that lacked this protein hyperaccumulated neddylated CDC53 
Cullin (Fig. I 0 (D)). Thus, the role of JAB ]-like proteins as deneddylating enzymes is highly 
conserved. JAB I was originally described as a JUN activation domain binding protein and was 
shown to interact with JUN and coactivate JUN mediated gene expression (Claret et al., 1996). 
Recently, mammalian JAB I was reported to bind a number of other proteins: 
lutropin/choriogonadotropin receptor (LHR) (Li et al. , 2000) and CDK inhibitor p27 (Tomoda et 
al., 1999), which are targeted for degradation by binding to JAB I; as well as LFA I integrin 
(Bianchi et al., 2000) and MIF cytokine (Kieemann et al., 2000), which seem to regulate JAB I 
activity through an unknown mechanism. The network of JAB I interactors and its connection to 
Signalosome function remained enigmatic for several years now. Our data indicate that 
Signalosome binds SCF and, possibly, other Cull in-based ubiquitin ligases and negatively 
regulates their functional outputs by controlling Cullin deneddylation through JAB I. An 
alternative, though less likely, interpretation is that Signalosome activates SCF through some 
other yet to be discovered mechanism, and the observed hyperneddylation of Pcu I results from a 
feedback loop mechanism that compensates for loss of SCF activity in the CSN mutant cells by 
hyperneddylating Pcu I. Our data suggests that JAB I interacting proteins are either regulators of 
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JAB I deneddylating activity or substrates of JAB I deneddylating enzyme. Our observation that 
multiple Nedd8-modified species accumulate in L1caa / cells suggests that additional neddylated 
cellular proteins and ubiquitin ligases are regulated by COP9 Signalosome and will be discovered 
in the near future. 
Experimental Procedures 
HeLa a nd NIH 3T3 cell transfections, lysate preparation, immunoprecipitations, and 
protein sequencing were performed as described previously (Lyapina et al. , 1998), (Seol et a l., 
1999). 
S. pombe manipulations and indirect immunofluorescence were performed according to 
protocols published in http://www.bio.uva.nl/pombe/handbook/ 
Subcellular fractionation. Strains were grown in YES media until OD595=0.5, harvested and 
washed in ice cold 'stop' buffer (50 mM NaF, I 0 mM TRIS 7.5, and 0.02% NaAzide) and re-
suspended in 600 j..lL BufferS (1.4 M Sorbito l, 40 mM HEPES (pH 7.2), 0.5 mM MgC12). 
Spheroplasts were made by incubating the cell suspension at 30°C for 40 min in the presence of 
I 00 j..lg/mL zymolyase (ICN). Cells were washed twice in I mL of ice cold Buffer F (20 mM 
HEPES (pH 7.2), 0.5 mM MgCI2) supplemented with protease inhibitor mix (PIM; I mM PMSF, 
I mM benzamidine, 0.25 j..lg/mL pepstatin, and 5 j..lg/mL each of leupeptin, aprotinin, and 
chymostatin) and 18% Fico II 400 (w/v). Cells were gently lysed in 200 j..lL of the same buffer 
using a stai nless steel pestle (VWR). To remove unlysed cells, the suspension was gently 
centrifuged (2000 Krpm). Intact nuclei were isolated by layering the supernatant on I 00 j..lL 
Buffer F supple mented with PIM, 7% Ficoll 400 (w/v), and 20% glycerol, fo llowed by gentle 
centrifugation. Nuclei were lysed in 200 j..lL of 20 mM HEPES (pH 7.2), 500 mM NaCI, I% 
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triton X-1 00, I mM EDTA, plus PIM. Cytosolic and nuclear fractions were analyzed by SDS-
PAGE fo llowed by Weste rn blotting. Cytoplasmic and nuclear fraction purity was confirmed 
using antibodies specific to Mcm5 (from S. Forsburg) and S. cerevisiae pyruvate kinase (from J. 
Thorner), respectively. 
Lysis Method. Strains were grown in YES (fi ssion yeast) or YPD (budding yeast) media to 
0 0 595=0.5, harvested, and washed in ice cold 'stop' buffer (50 mM NaF, I OmM Tri s 7 .5, and 
0.02% Na azide). Cells were resuspended in an equal volume of Lysis Buffer (20 mM HEPES 
(pH 7.2), 150 mM NaCI, 0.2% triton X- 100, 10 mM EDTA, 50 mM NaF, mM DTT) 
supplemented with PIM. An equal vo lume of g lass beads was added (0 .5 J..lm Sigma). Cells were 
vortexed at maximum speed 6 times for 30 seconds. Lysates were c leared by centrifugation. 
Protein concentrations were dete rmined using Bio-Rad prote in assay. Lysates were used in 
deneddylation assays as indicated. For immunoprecipitations, lmg of extract was used with 0.5 
J..lg of the indicated antibody. 
CSN purification was performed as described (Wei and Deng, 1998). 
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Figures 
Figure 1. Identification of SCF interacting proteins by mass spectrometry. 
Mouse NIH 3T3 cells were infected with retroviruses that expressed Myc9-TEV-tagged hSKP2 or 
hCULI D.C. Cell extracts prepared from uninfected (lane I) cells and cells infected with SKP2 
(lanes 2) or CUL I b.C (lane 3) retroviruses were adsorbed to anti-Myc beads, eluted with TEV 
protease (Gibco BRL), and analyzed by SDS-PAGE. Specific bands were excised from the gel 
and protein identity was determined by mass spectrometry as described (Shevchenko et al., 1996). 
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Figure 2. COP9 Signalosome association with hCULI does not depend on CULl neddylation. 
HeLa ce lls were transiently transfected with pCEP4 vectors that expressed full length (lane 2) or 
C-terminally truncated (lacking the NEDD8 modification site) forms of Myc9-hCUL I ( lane 3). 
The Cullins and associated proteins were retrieved on anti-Myc beads, separated by SDS-PAGE, 
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Figure 3. Association of Cul lins and SCF components with COP9 Signalosome. 
HeLa cells were transiently transfected with vector alone (lanes I, 3) or with a vector that 
expressed F lag-tagged CSN I subunit of COP9 S ignalosome (lanes 2, 4). CSN I complexes (lanes 
3, 4) were purified on anti-Flag beads, eluted with F lag peptide, resolved by SDS-PAGE, and 
probed for associated endogenous protei ns with various antibodies as indicated. For comparison, 
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Figure 4. CSN overexpression in HeLa cells prevents llcBa degradation in response to TNFa. 
A. HeLa cells were transiently transfected with pCMV4-HA-IKBa and pCS2+[3-Galactosidase 
vectors with or without either [3TrCPf1F (F-box deletion mutant of [3TrCP) or Flag-CSN I 
expression vectors. 36 hrs post-transfection cells were treated with I 00 !J.M proteasome inhibi tor 
LLnL for 6 hrs, 1 !J.M of protein phosphatase inhibitor Calyculin A for 3 hrs, and I 0 nM TNFa 
for 15 min, as indicated. Cells lysates were prepared, normalized for [3-Galactosidase activity, 
and analyzed by SDS-PAGE followed by Western blotting with anti-HA antibodies. Co-
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expression of either ~TrCP~F or Flag-CSN I prevented HA-
IKBa degradation in responce to TNFa. 
B. 293T cells were transiently transfected with a mixture of plasmids expressing Flag-CSN I, 
HA-IKKEE, and wt or S32,36A mutant of HA-IKBa, as indicated. Cells lysates prepared 36 hrs 
post-transfection were incubated with anti-Flag beads for I hr at +4°C. The beads were washed 
three times with lysis buffer, boiled in SDS-PAGE loading buffer, and associated proteins were 
res loved by SDS-PAGE and visualized by Western blotting with anti-HA and anti-CSNI 




I. Substrate localization 
SCF 
~ 
2. Kinase/phosphatase activity/localization 
3. SCF activity/localization 
4. Proteasome targeting 
83 
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Figure 5. Regulation of IKBa. degradation by COP9 Signalosome. 
CSN can potentially impact IKBa. degradation at each step involved in this process. Since 
IKBa. is known to shuttle in and out of the nucleus, CSN might be involved in IKBa. and/or SCF 
localization. Alternatively, CSN might regulate IKK activation/IKBa. phosphorylation, 
recognition of phosphorylated IKBa. and its ubiquitination by SCF, targeting of ubiquitinated 
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Figure 6. S. Pombe Cu llin I (Pcu I) associates with COP9 Signalosome. 
A. Untagged (lanes 2 and 6), caa/Myc (lanes 3 and 7), and pcu/Myc (lanes 4 and 8) strains were 
transformed with a pRep41-based plasmid that expressed HA-tagged CSN subunit Sgn211 A. 
Extracts prepared from these strains were either evaluated directly (left panels), or were first 
immunoprecipitated w ith anti-Myc antibodies (right panels) prior to SDS-PAGE followed by 
Western blotting with anti-Myc and anti-HA antibodies, as indicated. B. Same as panel A, except 
association of endogenous Pcu I with Caa I Myc (lane 5) or Sgn211A (lane 6) was evaluated by anti-
Pcu I Western blot of anti-Myc and anti-HA immunoprecipitates (lanes 4-6), respectively. 
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Figure 7. Pcu I hyperaccumulates as a neddylated species in LJ.caal cells. 
A. Extracts from wt and various deletion and point mutant strains were probed with anti-Pcu I 
antibodies to detect endogenous Pcu I. B. Wt and LJ.caa/ mutant cells were transformed with 
pRep41 plasmids that expressed Myc-tagged wt or K713R mutant Pcu I that lacks the 
neddlylation site. Crude extracts from these strains were probed with a-Myc antibodies to detect 
Pcu I. C. Wt and LJ.caal strains were transformed with a plasmid that expressed HAr tagged 
Brassica napus Nedd8 from the inducible nmtl promoter. Crude lysates (lanes 1-4) and anti-
Pcu I immunoprecipitates (lanes 5-8) from wt and LJ.caal strains ( 12 hrs post induction) with 
(lanes I ,2,5,6) or without (lanes 3,4,7,8) the plasmid were immunoblotted with anti-Pcu I (top 
panel) or anti-HA (bottom panel) antibodies to detect Pcu 1-11A3Nedd8 conjugates. D. The strains 
described in panel C were harvested 12 hrs after induction of the nmt promoter to minimize 
overexpression of HA3Nedd8, and lysates were sequentially immunoprecipitated and 
immunoblotted with anti-HA antibodies to detect 11A3Nedd8 conjugation to cellular proteins. 
* indicates the position of the heavy and light antibody chains. 
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Figure 8. SCF composition is unperturbed and SCF activity is slightly increased in !J.caal 
mutant cells. 
A. Western blot analysis of SCF subunits in various mutant strains. Extracts (30 ~g) from wt, 
!J.caa/, !J.popl, and CDC20 mutant strains were resolved by SDS-PAGE and analyzed by western 
blotting with a-Pcul, a-Psh l , and a-Pip I antibodies. B. SCF assembly in wt and !J.caal strains. 
SCF subunits were evaluated in crude lysates (lanes 1-3) or in anti-Myc immunoprecipitates 
(lanes 4-6) from pcul rnyc 13+ or !J.caal pcu/ rnyc 13+ strains. Wt untagged stain was used as a 
negative control (lanes I and 4). Psh I and Pip I binding to Pcu I was analyzed by Western 
blotting with the respective antibodies. C. Analysis of SCF activity in wt and !J.caa l strains. 
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Lanes 1-3: SCF complexes purified from wt and t1caal strains via the Myc epitope on 
endogenous Pcu1Mycl 3 were washed and incubated in the presence oe2P-Ub, ATP, El, and 
hCDC34 for I hr at 30°C. Formation of 32P-Ub conjugates C2P-Ub") was analyzed by SDS-PAGE 
followed by autoradiography. An untagged pcul+ strain was used as a negative control (lane I). 
Lanes 4-6: SCF complexes immunopurified from wt and t1caal strains using anti-Pcu I antibodies 
were washed and incubated in the presence of Ub, ATP, E I, and hCDC34 for I hr at 30°C. 
Formation of Ub conjugates (Ub") was analyzed by SDS-PAGE followed by Western blotting 
with anti-Ub antibodies (Chemicon). As a negative control, Pcu I antibody was omitted from the 
immunoprecipitation (lane 4). The amount of Pcu I in the reactions was monitored by reblotting 
the same nitrocellulose with anti-Pcu I antibodies (lanes 4-6, bottom panel). D. Analysis of Pcu I 
localization by immunofluorescence. Pcul localization was visualized in pculmyc/3+ and t1caal 
pcu I myc 13+ strains by immunostaining with mouse anti-Myc antibodies followed by anti-mouse 
IgG-FITC antibodies and confocal microscopy. E. Analysis of Pcu I localization by subcellular 
fractionation. Proteins in the nuclear (lanes 5-8) and cytoplasmic (lanes 1-4) factions derived 
from homogenized spheroplasts were resolved by SDS-PAGE and analyzed by Western blotting 
with indicated antibodies. Antibodies against known cytoplasmic (pyruvate kinase) and nuclear 
(Mcm5) proteins were used to monitor the efficiency of the fractionation procedure. 
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Figure 9. Co-purification of Cullins and SKP I with COP9 Signalosome. 
COP9 S ignalosome (CSN) was purified by conventional chromatography using five different 
res ins as described (Wei and Deng, 1998). Protein fractions coming off the last, gel filtration 
(Superose 6), column were collected and analysed by SDS-PAGE followed by Coomassie 
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staining (panel A). Arrows indicate CSN subunit positions in the gels. Superose 6 fractions form 
a different purification were analyzed by SDS-PAGE and silver staining (panel B) and Western 
blotting with indicated antibodies (panel C). Cullins I , 2, and 3, as well as SKP I, were co-
fractionating with CSN through all purification steps. 
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Figure 10. Cop9 Signalosome has deneddylating activity. 
A. Coomassie stai n of CSN purified from pig spleen. B. Wild typeS. pombe extracts and 
purified pig spleen CSN possess deneddylating activity. Extract (40 1-1g) from i1caal cells was 
incubated separately, or in the presence of purified pig CSN (3 1-1g) or pcul myc 13+ cell extract ( 40 
1-1g) for 30 minutes at 30°C in the presence or absence of I OmM NEM, as indicated. Pcu I 
neddylation was evaluated by SDS-PAGE followed by western blotting with anti-Pcu I 
antibodies. C. Purified Pcu I M yc i J is deneddylated by purified pig CSN. Pcu I Myc i J was 
immunoprecipitated from i1caal extracts using anti-Myc antibodies. Antibody beads were 
washed five times with lysis buffer and incubated for the indicated times at 30°C in the presence 
or absence of 3 J..lg of purified CSN. D. Deletion of the Jab I homologue inS. cerevisiae 
(YDL216c) results in the hyperaccumulation of a modified form of CDC53. Total cell lysate (30 
1-1g) from wt and YDL216i1 strains was separated by SDS-PAGE and evaluated by western 
blotting with anti-CDC53 antibodies. 
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ABSTRACT The SCF ubiquitin ligase complex of budding 
yeast triggers DNA replication by cata lyzing ubiquitination of the 
S phase cyclin-dependent kinase inhibitor SICl. SCF is com-
posed of three proteins- ySKPl, CDC53 (Cullin), a nd the F-box 
protein CDC4-that a re conserved from yeast to humans. As 
par t of an effort to identity components and substrates of a 
putative human SCF complex, we isola ted hSKPl in a two-hybrid 
screen with hCULI, the closest human homologue of CDCSJ. 
Here, we show that hCULl associates with hSKPl in vivo a nd 
directly interacts with both hSKPl and the huma n F-box protein 
SKP2 in vitro, forming a n SCF-Iike particle. Moreover, hCULl 
complements the growth defect of yeast cdc53ts mutants, asso-
ciates with ubiquitination-promoting activity in huma n cell 
extracts, a nd can assemble into functiona l, chimeric ubiquitin 
ligase complexes with yeast SCF components. Taken together, 
these data suggest that hCULl functions as part of a n SCF 
ubiquitin ligase complex in human cells. Further application of 
biochemical assays similar to those described here can now be 
used to identity regulators/ components of hCULl -based SCF 
complexes, to determine whether the hCUL2-hCULS proteins 
also are components of ubiquitin ligase complexes in human 
cells, and to screen for chemical compounds that modulate the 
activi ties of the hSKPI a nd hCULI proteins. 
The irreversible nature of proteolysis makes it well suited to serve 
as a regulatory switch for controll ing unidirectional processes. 
This principle is clearly evident in the o rganizatio n of the cell 
division cycle, where initiation of DNA replicatio n, chromosome 
segregation, and exit from mitosis a rc triggered by the destruction 
of key regulatory proteins (1-3). 
Proteins typically are marked for proteolytic degradation by 
attachment of multiubiquitin chains. This process is in itiated by 
a ubiquitin-activating enzyme (E I), which activates ubiquitin by 
adenylation and becomes linked to it via a thiolcstcr bo nd. 
Ubiquitin then is transferred to a ubiquitin-conjugating enzyme, 
E2. Whereas E2s can attach ubiquitin directly to lysine residues 
in a substrate, most physiological ubiquitination reactions prob-
ably require a ubiqui tin ligase, or E3 (4). E3s have been impli-
cated in substrate recognition and, in one case, transfer of 
ubiquitin from E2 to a substrate via an E3-ubiquitin-thiolcstcr 
intermediate (5). Once the substrate is multiubiquitinatcd, it then 
is recognized and degraded by the 26S proteasomc. 
A ubiquitination pathway recently has been discovered in 
budding yeast ( I, 6, 7). Components of this pathway include the 
CDC53, CDC4, and ySKPl gene products, which assemble into 
a ubiquitin ligase complex known as SCf'C°C4 (for SKP I, Cullin, 
F-box protein CDC4); because several of the yeast and human 
subunits have identical names-e.g., SKPI-wc distinguish them 
with the letters y or h, respectively. SCf'CDC4 collaborates with the 
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E2 enzyme yCDC34 to catalyze ubiquitination of the cyclin-
dcpcndcnt kinase (CDK) inhibitor SIC !. The specificity of 
SCP:'DC4 is thought to be governed by ySKP I and the F-box-
containing subunit CDC4, which together for m a substrate 
receptor that tethers SIC I to the complex. The assembly of this 
receptor is thought to be mediated by a direct interaction between 
ySKP I and the F-box do main of CDC4 (6, 7). 
Whereas genetic analysis has revealed that SIC ! proteolysis 
requires CDC4, G 1 cyclin proteolysis appears to depend on a 
distinct F-box-containing prote in known as G RR I (8). Alte rna-
tive SCF complexes (SCp:iRR 1) assembled with G RR I instead of 
CDC4 bind G 1 cyclins but not SIC l , suggesting that there exist 
multiple SCF complexes in yeast whose substrate specificities arc 
dictated by the identity of the F-box subunit (7). 
Components of the SCF ubiquitination pathway have been 
highly conserved during evolution. Human homo logues of 
yCDC34 and ySKP I have been repo rted (9, I 0), and F-box-
containing prote ins like CDC4 and GRRl have been identified 
in many cukaryotes ( I l ). Many of these F-box proteins also 
contain e ithe r WD-40 repeats (such as CDC4) or leucine-rich 
repeats (such as G RR I). A potential human cou nterpart of 
G RR I, SKP2, has been identified along with hSKP I as a Cyclin 
A/CDK2-associatcd protein that is necessary for S-phase pro-
gression ( I 0). Homologues of CDC53, which arc known as 
Cull ins, a lso are present in many eukaryotcs, including humans 
and nematodes ( 12, 13). 
Studies in budding yeast suggest that SCF substrates must be 
phosphorylated before they can be ubiquitinatcd ( 14, 15). Several 
human cell cycle regulato rs arc targeted for ubiquit ination after 
their phosphorylation by CD Ks, implicating them as potential 
substrates o f an SCF pathway(s) in human cells. Among them is 
the CDK inhibitor p27, the abundance of which may be regulated 
by CDC34-dependent ubiquitinatio n ( 16, 17). In addition, Cyclins 
E and D I arc degraded by a ubiquitin-dcpcndcnt pathway after 
phosphorylation at a specific site ( 18-20). The observation that 
Cyclin A/ CDK2 associates prefe rentially with hSKPI and SKP2 
in transformed cells to the exclusion of a proli ferating cell nuclear 
antigen and p21 ( 10) raises the possibil ity that Cyclin A is also a 
target of an SCF pathway. Alternatively, SCF-bound Cyclin 
A/ CDK2 may phosphorylate SCF subu nits or potentia l sub-
strates such as E2F-1/ DP- 1, thereby activating SCF-dcpcndcnt 
ubiquitination (21, 22). 
Despite the conservation of SCF components from yeast to 
humans, several observations raise the questio n of whether the 
metazoan homologues arc actually compo nents of SCF-Iikc 
ubiquitin ligases. First, whereas Saccharomyces cerevisiae cdc5J~> 
mutants arrest at the G 1/ S transition, Caenorhabditis elegans cul-l 
mutants fail to exit the cell cycle, resulting in hyperplasia of most 
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larval tissues ( 12). It is unclear whether this discrepancy arises 
because cul-l and CDC53 have different functions or because 
they are components of distinct ubiquitin ligase complexes with 
different substrate specificities. Second, the recent discovery of 
ubiquitin-like proteins (RUB1/ NEDD8 and SMT3/ SUMO I) 
that are conjugated to proteins by pathways that involve El and 
E2 homologs (23) suggests that some homologs of SCF compo-
nents might function in these alternative pathways. Indeed, 
attachment of RUB I to CDC53 fails to occur in skpl mutants, 
suggesting that ySKPl may be involved directly in the "rubiny-
lation" of CDC53 (24). Third, the best characterized human 
Cullin, CUL2, assembles with the von Hippel-Lindau tumor 
suppressor protein/ Eiongin B/ Eiongin C complex that has been 
suggested to regulate mRNA transcript elongation and accumu-
lation of hypoxia-inducible mRNAs (25, 26). Fourth, ySKPl is a 
subunit of the centromere-binding CBF3 complex, suggesting 
that vertebrate SCF subunits may serve as components of a 
variety of unrelated molecular machines (34). 
To address whether SCF-Iike activities are present in animal 
cells, we sought hCULl binding partners, and we tested whether 
putative human SCF subunits can assemble together to yield 
complexes with ubiquitin ligase activity. We report here that 
hCULl is a direct functional homologue of CDC53 because it can 
suppress the temperature-sensitive growth of cdc53 mutants, can 
associate with ubiquitin-conjugation activity in human celllysates, 
and can substitute for CDC53 in the reconstitution of SICI 
ubiquitination with purified components. Moreover, hCUL1 
directly binds to the putative SCF subunits hSKP1 and SKP2. 
Taken together, these data provide strong evidence that an 
SCF-dependent ubiquitination pathway is conserved from yeast 
to mammals. 
MATERIALS AND METHODS 
Yeast Strains and Reagents. Yeast strains, plasmids, and a 
HeLa eDNA library for the two-hybrid screen were a generous 
gift from R. Brent (Massachusetts General Hospital). Wx131.2c 
cdc53-2" strain was obtained from M. Goebl (Indiana Univer-
sity). Baculoviruses expressing hCDK211 A, hCyclin A (D. Mor-
gan, University of California, San Francisco), SKP2 (H. Zhang, 
Yale University), hSKPl (P. Sorger, Massachusetts Institute of 
Technology) and plasmids pGEX-KG-hSKPl and pGEX-KG-
SKP2 (P. Jackson, Stanford University) and pCS2+ n{3gal and 
pCS2+HA-SMC1 (S. Handeli, Fred Hutchinson Cancer Re-
search Center) were kindly provided by the indicated investiga-
tors. Other baculoviruses have been described (6). Ubiquitin and 
the Protein Biotinylation Kit were purchased from Sigma, and 
biotinylated ubiquitin (BUb) was prepared according to the 
manufacturer's instructions. Ubiquitin aldehyde was a generous 
gift from R. Cohen (University of Iowa). 
Plasmid and Baculovirus Construction. Full-length hCULI 
ORF was assembled from expressed sequence tags HE2AB96 
and HSY AD74 and subcloned into pRS316 and pMALc (New 
England Biolabs). The same hCULl fragment also was subcloned 
into pYL1393 (PharMingen) to generate a hCULl-expressing 
baculovirus. An N-terminal epitope-tagged version of hCULl 
was constructed by inserting a DNA cassette that contains two 
tandem repeats of the Polyoma epitope (MEYMPME) followed 
by six histidine residues (designated as PHis6) into pRS316-
hCUL1. Pllis6 hCUL1 fragment then was subcloned into pFAST-
BACl (GIBCO/ BRL) to generate a PHis6hCUL1 baculovirus and 
was subcloned into pDNA3.1 / Zeo (Invitrogen) to generate 
pcDNA3.1-PHis6-hCUL1. pCS2+ HA-hSKPl was generated by 
subcloning a hSKPl fragment from pGEX-KG-hSKP1 into 
pCS2+ HA-SMCl. 
Antibodies. Anti-hCULI antibodies were generated in rabbits 
immunized with either a fusion protein containing the first 41 
residues of hCUL1 followed by glutathione S-transferase (GST) 
(Babco, Richmond, CA) or a fusion protein containing GST 
followed by the last 86 residues of hCULI (California Institute of 
Proc. Nat/. Acad. Sci. USA 95 (1998) 
Technology antibody faci lity). Antibodies against hCULl and 
GST were affinity purified by using maltose binding protein 
(MBP) fusions of the corresponding peptides and GST, respec-
tively, as described (27). Monoclonal anti-Polyoma antibodies 
were bound to protein A-Sepharose beads and crosslinked to 
protein A with dimethylpimilimadate (27) at a concentration of 
= 2 mg of antibodies per ml of protein A resin. Anti-HA resin was 
generated by coupling 1 ml of anti-HA ascites to 1 ml of CNBr 
activated agarose (Pharmacia) according to the manufacturer's 
protocol. 
Expression and Purification of Proteins. Proteins expressed in 
bacteria or yeast were purified according to standard protocols 
and as described (6). For the expression and purification of 
chimeric SCF complexes, HiS insect cells were infected with 
baculoviruses expressing PIIACDC4 (PHA designates an epitope-
tag consisting of two tandem repeats of the Polyoma epitope 
followed by three hemagglutinin epitopes), CDC53PHA, 
PHis6hCULl (multiplicities of infection of 6), ySKPJHis6, or hSKP1 
(multiplicities of infection of 4). Cells were collected 72 hr 
post-infection, and lysates were prepared as described (6). The 
Polyoma tagged proteins were affinity purified from these lysates 
(6) to yield the various SCF complexes. 
Cell Cultures and Transfections. WI-38 human lung fibroblasts 
were purchased from ATCC. HeLa S3 cells were a gift from S. 
Handeli. Cells were grown in DMEM-F12 (GIBCO/ BRL) sup-
plemented with 10% fetal bovine serum (GIBCO/ BRL) at 
37°C/ 5%C02. Cells were transfected in 100-mm dishes by the 
modified calcium phosphate method (28). 10 !Lg pCS2+ HA-
hSKPl and 7.5 J.tg pcDNA3.1-PHis6-hCUL1 vectors were used 
per transfection plate. Transfection efficiency was monitored by 
cotransfection of 2.5 !Lg pCS2+ n{3gal plasmid per transfection 
plate followed by standard colorimetric {3gal assays (29). Total 
DNA concentration was 20 J.tg/ 100-mm dish and was adjusted for 
every transfection plate by adding empty vectors. Cells were 
harvested and lysed 24 hr post-transfection. 
Immunoprecipitations and Western Blotting. Baculovirus-
1 
infected insect cells were harvested and lysed at 48 hr (for Sf9 
cells) or 72 hr (for HiS cells) post-infection in 0.8 ml of lysis buffer 
per 100-mm plate (as described in ref. 6). Metabolic labeling was 
done by incubating insect cells for 3 hr in methionine-deficient 
medium plus 20 JLCi/ml ofTran[35S)-Iabel before lysis. Wl-38 and 
HeLa S3 cells were lysed in 0.4 ml of lysis buffer per 100-mm 
plate. Lysates were cleared by centrifugation at 14,000 X g for 15 
min, were adjusted to 10% glycerol, were frozen in liquid nitro-
gen, and were stored at - 80°C. Celllysates (1 mg) were incubated 
with 50 JLI of antibody-coupled beads (1:1 suspension in lysis 
buffer) for 2 hr at 4°C. Precipitates were washed five times with 
1 ml of lysis buffer and were analyzed by SDS/ PAGE followed by 
Western blotting or autoradiography. Western blotting was per-
formed as described (27). PHis6hCUL1 and HAhSKPl were de-
tected by rabbit polyclonal anti-hCULl and biotinylated anti-HA 
(12CA5) primary antibodies and were visualized by incubation 
with goat anti-rabbit-horseradish peroxidase (HRP) and strepta-
vidin-HRP conjugates followed by ECL detection (Amersharn). 
Ubiquitination Reactions. Crude Sf9 cell lysates (500 J.tg) 
prepared from cells infected with Phis6hCUL1 baculovirus were 
incubated with 20 JLI anti-Polyoma beads for 2 hr at 4°C to allow 
Phis6hCULl binding. Beads were washed three times with lysis 
buffer and were incubated with 1 mg of crude HeLa S3 lysate 
overnight at 4°C. Beads then were washed three times with lysis 
buffer and were supplemented with 6 !Lg BUb, 500 ng hCDC34, 
25 ng His6yUBAl, 1 JLI of lO X ATP-regenerating system (6), 1 1-d 
of lO X reaction buffer (6), and 0.5 JLM ubiquitin aldehyde. 
Reactions were adjusted to 10 JLI by adding 20 mM Hepes (pH 
7.6), 100 mM potassium acetate, 1 mM DTT, were incubated for 
90 min at 30°C, and were terminated by adding Laemmli sample 
buffer. Samples were analyzed by Western blotting with strepta-
vidin-HRP conjugate. All ubiquitination reactions with chimeric 
SCF complexes were performed as described (6). 
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FIG. I. hCULI and hSKPl interacl in ••i•·o. (A) hCULI detection by affinity-purified anti-hCUL I an tibodies. Crude human cell lysates (50 !Lg) 
(lanes I, 2, 6, and 7) and 0.5 ILg of crude lysates from HiS insect cells, uninfected (lanes 5 and 10) or infected with hCUL I (lanes 3 and 8) or 
~' 11"6hCULI (lanes 4 and 9) viruses, were resolved on an 8% SDS-polyacrylamide gel, transferred to a PVDF membrane, a nd probed with 
anti-hCULI antibodies. 04, serum raised against C-terminal part of hCULI; N I, serum raised against N-term inal part of hCULI. Asterisk designates 
putative N-terminally truncated hCULI that is recognized by C-terminal antibody. (/J) !-leLa S3 cells were transfected with pcDNA3.1-PHis6-
hCULl (lanes I, 4, and 7), pCS2+ 11 A-hSKP I (lanes 3, 6. and 9), or both plasmids (lanes 2, 5, and 8). Lysates ( I mg) were prepared 24 hr 
post-transfection and were immunoprecipitated with anti-Polyoma (lanes 4-6) or anti-H A (lanes 7-9) beads. Proteins reta ined on the beads were 
analyzed by Western blotting. Lanes 1-3 contained 20 ILg of crude lysates. 
RESULTS 
Human CULl-Interacting Proteins. To identify human pro-
teins that interact with hCULI , we performed a two-hybrid 
screen (30, 3 1 ). A full-length hCULJ eDNA, fused to the LcxA 
DNA-binding domain, was used as a bait to identify cDNAs fro m 
a HeLa library that encode hCULI interactors. This screen 
yielded clones encoding hSKP I, protein phosphatase 2A cata lytic 
subun it, and the 20S proteasomc subuni t HsN3. None of these 
clones interacted with LexA-hCDK2 or LexA-Lamin C baits, 
suggesting that their interaction with LcxA-hCULI was specific. 
He re, we examine in detail the interaction of hCULI with hSKP I 
(see below). The physiological significance of the interaction of 
hCULl with HsN3 or protein phosphatase 2A has not been 
evaluated yet. 
Human CULl Interacts with hSKPI in Vivo. The identification 
of hSKPJ as a hCULJ-interacting protein suggested that these 
proteins may be subunits of a complex in human cells that is 
similar to the SCF ubiquitin ligase of budding yeast. To test 
whether hCULJ interacts with hSKP I in vivo, we prepared 
affinity-purified rabbit polyclonal antibodies directed against the 
N and C termini of hCULl. Fig. lA shows specificity of the 
affinity-purified antibodies. Both antibodies recognized one ma-
jor polypeptide of = 80 kDa in transformed (HeLa S3) and 
nontransformed (WI-38) cell lines (Fig. l A, lanes I, 2, 6, and 7). 
This species comigrated with hCULI produced in HiS cells 
infected with a baculovirus that contains full length hCULJ 
eDNA (Fig. l A, lanes 3 and 8) . A more rapidly migrating species 
of recombinant hCULl detected in HiS cells by the anti-C-
terminal antibodies (Fig. lA, lane 3) presumably represents a 
breakdown product or initiation of translation downstream of the 
normal start codon because this species was not detected by the 
anti-N-terminal antibodies. As expected, addition of a Polyoma 
antigen-hexahistidine tag to hCULJ (~' 1 1 i'6hCULJ) yielded a more 
slowly migrating hCULJ band (Fig. lA, lanes 4 and 9). 
Neither polyclonal antibody precipitated hCULl from crude 
human cell lysatcs, precluding analysis o f hCULI complexes in 
nontransfected cells. Thus, to evaluate the potential interaction of 
hCULl with hSKP I in vivo, we transfectcd He La S3 cells with 
PHis6hCULI and 11AhSKPl expression vectors. Lysates were pre-
pared from these cells 24 hr post-transfection and were immu-
noprecipitated by using crosslinked anti-Polyoma or anti-HA 
antibody beads. Proteins bound to the beads were separated by 
SDS/ PAGE and were analyzed by immunoblotting with anti-
hCULl and anti-HA antibodies (Fig. 18). Consistent with the 
two-hybrid data, hCULJ was detected specifically in hSKP I 
immunoprecipitatcs and vice versa. 
Human CULl, hSKPl, and SKP2 Assemble into an SCF-Iike 
Complex that Can Associate with Cyclin A/ CDK2 Kinase. Hu-
man SKP I was initially identified as a Cyclin A/ CDK2-associatcd 
protein in transformed human cells ( I 0). This association is 
mediated by SKP2, a human F-box protein with leucine-rich 
repeats, reminiscent of the G RRI protein. CDCS3 and ySKPL, 
together with the F-box protein GRR I, constitute a putative 
SCfGRRI ubiquitin ligase complex that targets G 1 cyclins for 
degradation (6, 7). The homology of hSKP I, SKP2, and hCULI 
proteins wi th components of the ySCF complex suggests that the 
human proteins may form a similar complex. We addressed this 
possibility by immunoprccipitating ~' 11 ;'6hCUL I from [35S]-
Iabclcd insect cells infected with baculoviruses that express 
l'lli'6hCULI, hSKPI , and SKP2 (Fig. 2A) and by testing whether 
hCULI can assemble with a previously described complex con-
taining Cyclin A/ CDK2, hSKPl , and SKP2 (Fig. 28). The 
interaction of hCULI with the Cyclin A/ CDK211A / hSKP J / SKP2 
complex was monitored by immunoprecipitating CDK211A from 
[ 35SJ-Iabclcd insect cells infected with all five viruses in various 
combinations. As shown in Fig. 2A, Pl li'"'hCULl efficiently as-
sembled with hSKPJ and SKP2, suggesting that these proteins 
form a terna ry complex similar to ySCF. Surprisingly, hCULI 
interacted with Cyclin A/ CDK211A complexes in the absence of 
SKP2 or hSKPl (Fig. 28, lane 6; note that hSKPl does not 
associate with Cyclin A/ CDK211 A complex in the absence of 
SKP2). This inte raction may be caused by e ither a direct inter-
action between hCULL and Cyclin A/ CDK211 A or the presence 
of a bridging protein in insect cells (e.g., sec ref. 6). Regardless, 
the ability of hCULI expressed in insect cells to assemble into 
complexes containing a cyclin-dependent kinase is likely to be 
physiologically significant because Pllis6hCULI immunoprecipi-
tatcs prepared from HcLa S3 cells contained histone HI kinase 
activity (data not shown). 
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FIG. 2. !Iuman CU Ll can interact with human SKPI , SKP2, and 
Cyclin A/ CDK2. Sf9 insect cells were infected with baculovirus 
constructs that express various human proteins as indicated. Cells were 
labeled with Tran[35SJ-label for 3 hr before harvesting. Pllb6hCULl 
(A) and CDK211A (B) together wi th associated proteins were immu-
noprecipitated by anti-Polyoma and anti-HA beads, respectively. The 
composilion of the protein complexes in the immunoprecipitates was 
analyzed by SDS/ PAGE followed by autoradiography. 
















FIG. 3. flu man CULl binds directly to hSKP I and SKP2. MBP, 
MBP-hCU LI , GST, GST-hSKPI , and GST-SKP2 were expressed 
individually in and purified from bacteria. Each protein was present in 
the binding reactions a t 65 ,_..g/ ml. Proteins ( 4 ,_..g o f each) were loaded 
in lanes 1-5. which represen ts I /5 of the input for the binding 
reactions. Prote ins were mixed as indicated (lanes 6-1 0) and incubated 
on icc for I hr. GST and GST fusions were collected on glutathionc-
Sepharose (GSH-Sepharose) for I hr a t 4°C, and the beads the n were 
washed three times with 20 mM llcpcs (pll 7.6), 150 mM NaCI , 0.1 % 
Triton X- 100, 5 mM MgCI 2, 5 mM E DTA, and 2 mM DTT. Proteins 
bound to gluta thionc-Scpharose were resolved by SDS/PAG E and 
were visua lized by sta ining w ith Coomassic blue. Positions of the 
full-lcnglh fusion proteins arc indicated by the arrows. A n = 70-kDa 
band that copurificd wilh GST-SKP2 from baclcria is marked by an 
asterisk. 
Human CULl Directly Interacts with hSKPI and SKP2. The 
results in Fig. 2 suggest that hCULI , hSKPI , and SKP2 ca n 
assemble into an SCF-Iikc particle when cocxpressed in insect 
cells. Because of the strong conservation o f SCF components, 
however, these interactions might be mediated by other prote ins 
provided by the host cells (for an example, sec ref. 6). To test 
whe ther the observed interactions arc direct, we produced GST-
hSKPI , GST-SKP2, and MBP-hCULI in bacteria. The GST 
fusio ns (or unfused GST control) were mixed with MBP-hCU Ll 
o r MBP and were recovered by binding to glutathionc-Scpharosc 
beads. Bound prote ins were resolved by SDS/ PAGE and were 
visualized by Coomassic blue staining (Fig. 3). MBP-hCULI but 
not MBP bound specifically and efficiently to GST-hSKP I and 
GST-SKP2 but not GST. This result demonstrates that hCULI 
can bind to both hSKPI and SKP2 without the participation of 
other proteins. 
Human CULl Is Functionally Homologous to CDC53 and Can 
Form an Active Chimeric SCF Complex with ySKPJ and CDC4. 
The above observations indicate that hCULI , the closest human 
homologue of CDC53, can assemble with hSKPI and the F-box 
protein SKP2 into a complex reminiscent of the yeast SCf'GRRI 
complex. We next tested whether this complex-in the presence 
of hCDC34, E I enzyme, and ubiquitin- was able to ubiquitinate 
proteins that either bind to it (Cyclin A; ref. I 0), arc known to be 
degraded in S phase (Cyclin E, E2F-1; refs. 18, 19, 2 1, and 22), or 




FIG. 4. hCULI complements lhe cdc53" mutant phenotype. A 
cdc53-2" mutant stra in was transformed with pTS I61-CDC53 and 
pTS161-hCULI plasmids !hat a llow controlled expression of CDC53 
and hCULI from the galactose-inducible GAL/ promoter. The empty 
vector alone was used as a negative control. Seria l dilutions I/ I 0 of the 
individual transformants were spotted on synthclic galactose medium 
and were incubated for 5 days at restrictive (33°C) and permissive 
(24°C) tcmpcrawrcs. 
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FIG. 5. I Iuman CULl can interact with the yeast SCF components 
ySKPI and CDC4. ll iS insect cells were infected with hacu\oviru-. 
construc1s expressi ng variow, proteins as indicaled. Celb were labeled 
wilh Trani 15Sf-Jabcl for 3 hr before harvesting. Yem.t SKP J 11,, (A) and 
PIIACDC4 (B) Iogclhcr with associated protein~ were immunoprc-
Cipllalcd by ani I-liA and anti-Polyoma beads. respectively. The com-
posilion of the prole in complexes in the immunoprecipitalcs "as 
analyzed by SDS/ PAGE followed by au1oradiography. The asterisk 
marks an unidentified contaminanl 1ha1 migrates reproducibly faster 
than lhc aulhenlic hCULI. 
have been implicated as substrates of hCDC34 (p27; refs. 16, I 7). 
These efforts were unsuccessful (data not shown), raising the 
question of whether SCFSKPZ complexes possess ubiquitin ligase 
activity. Moreover, ubiquitin ligase activity of the analogous yeast 
SCf'GRRI complex has no t been demonstrated yet and might 
require additional unidentified components. However, we were 
able to address whether hCULl is a functional component of a 
ubiquitin ligase complex genetically and biochemically by taking 
advantage of the conside rable knowledge of this pathway in yeast. 
First, we asked whether IJCULJ can complement the cdc53" 
mutation. We introduced IJCULJ and CDC53 under the control 
of the GAL/ promoter into a yeast strain carrying a temperature-
sensitive mutation in the CDC53 gene. Individual transformants 
were spotted a t different dilutions on glucose (noninducing 
conditions, data not shown) and galactose (inducing conditions) 
media at permissive (24°C) and restrictive (33°C) temperatures 
(Fig. 4). Only transformants that expressed wild-type CDC53 or 
hCULI proteins were able to grow at the restrictive temperature. 
However, hCULI failed to complement a cdc53 null strain (data 
not shown). 
The ability of hCULI to complement the cdc531' mutation 
implied that hCULI can assemble into functional SCFcomplexcs 
with yeast proteins. To test this idea, we examined whether 
hCULI can interact with the budding yeast SCF subunits ySKP I 
and C DC4. A ll three proteins were cocxprcsscd in [35SJ-
mc thionine-radiolabclcd insect cells in various combinations, as 
indicated in Fig. 5. Human CULl specifically coimmunoprecipi-
tatcd with ySKPI 11A (Fig. SA, lane 2) or PHACDC4/ ySKP1 (Fig. 
58, lane 4), indicating that it can form a chimeric SC~DC4 
complex with yeast proteins. 
Our previous findings (6) identified SC~DC4 as a functional E3 
that required the presence of all three subunits (CDC4, CDC53, 
~lJld ySKP 1) to catalyze ubiquitination of phosphorylated S1C1 (6, 
7). Preceding its ubiquitination, phosphorylated SlCI is recruited 
to SCF coc4 by binding to the CDC4/ySKP I substrate receptor 
(6, 7). Given that hCULI and hSKPl assembled with CDC4 (Fig. 
58), we sought to test whether these hybrid SCF complexes were 
able to promote ubiquitination of phosphorylated SIC I. Purified 
chimeric SCF complexes were incubated with MBP-SICIMJJ"6 
and purified ubiquitination components. In the presence of 
SCFcoc4 (Fig. 6A, lane 1), MBP-SICIM11i'6 was converted effi-
ciently to high molecular weight forms. Omission of e ither CDC4, 
CDC53, or ySKPI resulted in no activity (Fig. 6A, lanes 2-4). 
Replacement of CDCSJPIIA with Pllis6hCULI resulted in an SCF 
complex with modest ubiquitination activity that depends on both 
CDC4 and ySKP I (Fig. 6A, lanes 5. 6, and 9). Additionally, an 
SCF complex containing both PH i'6 hCULI and hSKP I along with 
PIIACDC4 also was able to catalyze ubiquitination of MBP-
SICIMIJ i'ol• (Fig. 6A, lane 10). The conversion of MBP-SICIM 11" 6 
to high molecular weight forms by hybrid CDC4/ hCULJ / hSKPI 
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Fro. 6. SIC I is ubiquitinated by chimeric SCF complexes. (A) lli5 
insect cells were infected with various baculoviruses expressing 
PIIACDC4, CDC53~'11A (53), ~' 11 "6hCULl (C), ySKPJIIis6 (Y), or 
hSKPI (II ) as indicated. At 72 hr post-infection, lysates were prepared 
and SCF complexes were affinity purified on an anti-Polyoma matrix, 
and eluted complexes were incubated for 2 hr at 2SOC with MBP-
SICI M 11" 6 in the presence of 11 ''6yU BA I (EI), yCDC34 (E2), purified 
CLN2/GST-CDC2811 A/ CKSI, ubiquitin, and an ATP-regenerating 
system. At the end of the incubation, the samples were fractionated by 
SDS/ PAGE and were immunoblotted wi th anti-myc antibod ies to 
detect M BP-SIC I M 11" 6 . Bound antibodies were visualized by ECL. (B) 
The indicated SCF complexes were purified from baculovirus-infected 
in;ect celllysates and were incubated with the full set of ubiquitination 
components (lanes I and 4) or in the absence of CLN2/ GST-
CDC2811A/ CKSI (lanes 2 and 5) or ubiquitin (lanes 3 and 6). (C) 
Purified SCF complexes containing CDC53~'11 A (53), PHi'6hCULI 
(CULl), ySKPI' 1''b (Y), or hSKPI ( II) subunits were incubated with 
ubiquitination components containing ei ther yCDC34 (Y) or hCDC34 
(H). 
complexes required both substrate phosphorylation (Fig. 68, lane 
5) and the presence of ubiquitin (Fig. 68, lane 6). Interestingly, 
cocxprcssion of PIIACDC4, CDC53~'1 1 A, and hSKP I did not result 
in a functional SCF complex (Fig. 6A, lane 7). 
CDC53 was shown to interact with yCDC34 (32). Thus, we 
presumed that an SCF complex contain ing hCULI would prefer 
to usc hCDC34 as an E2 as opposed to yCDC34. However, 
SCFcoc4 complexes conta ining Pllis6 hCULI with e ither 
ySKP 111i'6 or hSKP I appeared to work much more efficiently with 
yCDC34 than with hCDC34 serving as the E2 (Fig. 6C, lanes 3, 
4, 7, and 8). Although we do not understand the basis for this 
preference, it is possible that there exist additional human 
CDC34-I ike E2s that interact preferentially with hCULI-
containing complexes. Alternatively, the interaction between an 
F-box subunit and an E2 enzyme might also contribute to the 
specificity for a particular E2 (38). 
Human CULl Assembles with Ubiquitination-Promoting Ac-
tivities in Human Cell Extracts. T he data presented so far arc 
consistent with hCU L I functioning as a component of a ubiquitin 
ligase complex in human cells. Because we have failed so far to 
detect ubiquitination activity by using recombinant hCULI / 
hSKP I / SKP2 complexes, we sought to develop an assay that 
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FIG. 7. Human CULl associates with ubiquitination activity in 
He La S3 lysates. (A) Anti-Polyoma beads were incubated in the 
presence of Pll"6hCULI , HeLa S3 lysates, or both as indicated, were 
washed five times with lysis buffer, and were mixed with the ubiquiti-
nation react ion components (Rxn mix) His6yU BA I, hCDC34, BUb, 
and ATP-regeneration system . Incorporation of BUb into proteins 
present in the reactions was monitored by probing with streptavidin-
HRP conjugate followed by ECL detection. (B) Plhs6hCULl alone or 
together with hSKPI and SKP2 was produced in insect cells and was 
bound to anti-Polyoma beads that then were washed and incubated at 
4°C in the presence or absence of crude He La S3 lysates to allow bead 
"activation" . Activated beads then were treated as in A . Dependence 
on the presence of ATP and BUb in the reactions was determined by 
omitting these components from the reaction mix (lanes 5, 8, and 9, 
respectively). The entire reaction mix was omitted in lane 10. Lane I 
contained reaction mix only. P-BUb., designates a ladder of ubiquiti-
nated proteins produced in the reaction. 
would a llow us to identify either substrates or cofactors of a 
hCULI-depcndcnt ubiquitination pathway. Pllis6hCULI pro-
duced in insect cells in the presence or absence of hSKPI plus 
SKP2 was bound to anti-Polyoma beads and incubated with crude 
He La S3 lysatcs to allow binding of other potential SCF compo-
nents, regulators, and substrates. After washing away unbound 
proteins, E1 , hCDC34, BUb, and an ATP-regenerating system 
then were added to the beads. After an incubation, reactions were 
fractionated by SDS/ PAGE, were transferred to nitrocellulose, 
and were blotted with streptavidin-HRP to detect ubiquitin 
conjugates. Whereas Phis6hCULI or Phis6hCULI / hSKP I / SKP2 
complexes isolated from insect cells exhibited little ubiquitination 
activity (Fig. 7A, lane 2 and Fig. 78, lanes 3 and 4), a high 
molecular weight smear characteristic of ubiquitinated proteins 
appeared (Fig. 7A, lane 3 and Fig. 78, lanes 6 and 7) when these 
same components were pre incubated with He La S3 lysate before 
the assay. In contrast, no signal was detected when naked 
polyoma beads were preincubated with HeLa S3 lysate (Fig. 7A, 
lane I). The appearance of slowly migrating biotinylated proteins 
depended on the addition of ubiquitin and ATP-regenerating 
system to the reaction (Fig. 78, lanes 8 and 9), indicating that the 
high molecular weight smear was caused by ubiquitination oc-
curring during the in vitro incubation. 
DISCUSSION 
Multiple homologucs of the ySKP I, CDC53, and F-box subunits 
of the SCF ubiquitin ligase complex have been identified (J0-13) 
and implicated in various cellular processes, including kineto-
chore function (33, 34), S-phase progression ( 10), exit from the 
cell cycle ( 12), transcript elongation, regulation of hypoxia-
inducible genes, and suppression of tumorigenesis (25, 26). Based 
on the close homology between hCULI and CDC53, we sought 
to address whether hCULI functions as part of an SCF-likc 
ubiquitin ligase complex in human cells. A two-hybrid screen to 
identify proteins that interact with hCULI yielded hSKPI , sug-
gesting that hCULI does indeed assemble into SCF-Iike com-
plexes in human cells. Several other observations reported here 
support this hypothesis. First, hCULI associates with hSKPI in 
transfccted HeLa S3 cells. Second, hCULJ assembles into com-
plexes with both hSKPl and the F-box protein SKP2 in vitro. 
Third, hCULJ complements the growth defect of a cdc5315 
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mutant. Fourth, hCULl and hSKPl can form chimeric SCF 
complexes with CDC4, and these complexes a rc able to ubiqui-
tinatc the SCFcoc4 substrate SlCl in vitro. Fifth, hCULl asso-
ciates with ubiquitination-promoting activity in HeLa S3 cell 
lysate. Taken togethe r, these data strongly suggest that hCULl is 
a subunit of an SCF-Iikc E3 complex in human cells. 
What are the candidate substrates for hCULl-dependent 
ubiquitination in human cells? SlCl, CLN2, and FARL must be 
phosphorylated before they can be ubiquitinated by the budding 
yeast SCF/ CDC34 pathway (6, 7, 35). The stability of many 
mammalian regulatory proteins-including TKB, ,(3-catenin, p27, 
Cyclin D, and Cyclin E- is known to be controlled by phosphor-
ylation (16-20, 36, 37). Furthe r work will be required to deter-
mine whether any of these proteins are substrates for human SCF 
complexes. SCF-associated Cyclin A might also be a substrate of 
the SCFSKP2 pathway. This is less likely, though, because Cyclin 
A is thought to be primarily destroyed via the antigen-presenting 
cell / cyclosome pathway, and both Cyclin A and SKP2 activities 
arc essential for entry into S phase (10). Instead, the tight 
association of Cyclin A/ CDK2 with SCF subunits both in vivo and 
in vitro might reflect an efficient coupling between substrate 
phosphorylation and ubiquitination in transformed cells. 
While this manuscript was in preparation, a study that com-
plements our findings was reported by Lisztwan et at. (38). These 
authors demonstrated that hCULl, hSKPl , and SKP2 assemble 
into a complex both in unperturbed and transfected human cells. 
Moreover, SKP2 a lso was shown to bind the ubiquitin-
conjugati ng enzyme hCDC34 in human cells, suggesting that 
SKP2 is pa rt of an SCF-Iike ubiquitin ligase. SKP2 also was shown 
to associa te with Cyclin A/ CDK2, and mutational analysis sug-
gested that Cyclin A/ CDK2 binding might regulate SKP2/ hSKP 1 
but not SKP2/hCULl inte raction in vivo. Our data support these 
findings and extend them by establishing that hCULl interacts 
directly with hSKP I and SKP2 without the participation of other 
eukaryotie proteins, and hCULl and hSKPl can assemble into 
active ubiquitin ligase complexes either in insect cells or in HeLa 
53 cell Jysates. 
Further characterization o f the SCF pathway in human cells 
will require the identification of functional F-box subunits and 
physiological substrates. The ability to stimulate the E3 activity of 
insect cell-derived hCULl with HeLa S3 cell lysate provides a 
strategy for identifying these proteins. Moreover, this assay can be 
adapted readily to test whether the related hCUL2-hCUL5 
proteins a lso assemble into ubiquitin ligase complexes in human 
cells. Lastly, by converting e ithe r the chimeric SCF complex assay 
(Fig. 6) o r the biotin-ubiquitin-based assay (Fig. 7) to a microtite r 
plate format, it should be feasible to screen chemical libraries to 
identify compounds that modulate the activities of hSKPl and 
hCULl. G iven its critical role in cell division in budding yeast, 
inhibitors of human SCF might be valuable lead compounds for 
the development of novel anti-cancer chemotherapeutics. 
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